<!DOCTYPE html>
<!-- saved from url=(0042)https://peptidestandard.com/store/aod9604/ -->
<html class="js no-touch" lang="en"><!--<![endif]--><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">

  <title>AOD-9604 - Peptide Standard</title>

  <meta property="og:title" content="AOD-9604"><meta property="og:url" content="https://peptidestandard.com/store/aod9604/"><meta property="og:type" content="article"><meta property="og:site_name" content="Peptide Standard"><meta name="description" content="





Molecular Formula - C78H123N23O23S2
Molecular Weight: 1815.1 u
Research Category - Weight Loss Research
Purity - 99.99%
Lab Tested - Yes
2MG

FULL CHEMICAL NAME
The full chemical name of AOD-9604 is Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe, corresponding to the amino acid sequence 177-191 of human growth hormone (hGH). This sequence includes tyrosine (Tyr) at the N-terminus, enhancing stability and bioactivity, followed by leucine (Leu), arginine (Arg), isoleucine (Ile), valine (Val), glutamine (Gln), cysteine (Cys), serine (Ser), glutamic acid (Glu), glycine (Gly), and phenylalanine (Phe). The peptide&amp;amp;rsquo;s structure is linear, with disulfide bonds potentially forming between cysteine residues, contributing to its lipolytic function without stimulating IGF-1 production, distinguishing it from full hGH.
ALIASES
Yes, AOD-9604 is also referred to by its synonym Tyr-hGH(177-191), which denotes its origin as the tyrosine-modified C-terminal fragment (amino acids 177-191) of human growth hormone. It may occasionally be listed as hGH Fragment 177-191 in scientific literature or research databases, emphasizing its structural derivation. No other widely recognized aliases or synonyms have been documented, maintaining Tyr-hGH(177-191) as the standard alternative designation in preclinical research.
&amp;amp;nbsp;
EMERGING TRENDS IN RESEARCH
Emerging trends in the literature suggest that AOD-9604 may have broader applications beyond its primary role in fat metabolism, including potential benefits for metabolic syndrome, insulin resistance, and dyslipidemia. Recent hypotheses propose it could modulate adipokine secretion (e.g., adiponectin, leptin) or enhance mitochondrial function in adipose tissue, improving overall metabolic health. There is also growing interest in its synergy with other anti-obesity agents, such as GLP-1 receptor agonists, though these ideas require validation through additional preclinical and clinical studies.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
Scientists are getting excited&amp;amp;mdash;AOD-9604 might not just burn fat but could also help with tricky health issues like sugar imbalances, cholesterol problems, or even body energy! They&amp;amp;rsquo;re guessing it might tweak fat signals or boost cell power in fat tissue, maybe teaming up with other weight-loss heroes&amp;amp;mdash;it&amp;amp;rsquo;s like a metabolic adventure waiting to unfold!
&amp;amp;nbsp;
NOTABLE INTERACTIONS
AOD-9604 primarily interacts with adipose tissue via its lipolytic effects, but preliminary research suggests potential interactions with &amp;amp;beta;-adrenergic pathways or PPAR&amp;amp;gamma; (peroxisome proliferator-activated receptor gamma) signaling, which regulate fat metabolism and insulin sensitivity. It may also influence adipokine production (e.g., adiponectin), though these interactions are not fully characterized and could affect systemic metabolic processes. No significant interactions with non-adipose systems (e.g., hepatic, renal) have been reported, but further studies are needed.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
AOD-9604&amp;amp;rsquo;s fat-burning magic might chat with other body systems&amp;amp;mdash;like the pathways that rev up fat breakdown or balance sugar, possibly tweaking fat signals too! It&amp;amp;rsquo;s like a backstage crew influencing the fat-burning show, but we&amp;amp;rsquo;re still figuring out the full cast in the lab&amp;amp;mdash;it could be a thrilling twist!
&amp;amp;nbsp;
PREPARATION INSTRUCTIONS
In preclinical studies, AOD-9604 has demonstrated quantifiable efficacy in reducing body fat. Human trials (Heffernan et al., 2001) reported a significant reduction in visceral and subcutaneous fat (up to 15% in obese individuals) after 12 weeks at doses of 450 &amp;amp;micro;g/day, with no significant increase in IGF-1 levels, confirming its separation from hGH growth effects. Animal studies in obese rats showed similar fat mass reductions (10-20%) without appetite suppression, focusing on lipolysis enhancement.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
In human tests, AOD-9604 melted away up to 15% of belly and body fat in just 12 weeks at 450 &amp;amp;micro;g/day&amp;amp;mdash;no growth hormone side effects like bigger muscles, just pure fat loss! In fat rats, it shaved off 10-20% of fat too, without making them less hungry&amp;amp;mdash;it&amp;amp;rsquo;s like a fat-burning wizard at work!
CONTRAINDICATIONS OR WARNINGS FOR RESEARCH USE
AOD-9604 is designated exclusively for research and is not approved for human therapeutic use. Standard warnings include &amp;quot;Not for human consumption,&amp;quot; &amp;quot;For laboratory use only,&amp;quot; and caution against use without Institutional Review Board (IRB) or Institutional Animal Care and Use Committee (IACUC) oversight, where applicable. No specific contraindications are identified beyond these, as safety data is primarily from preclinical and early human studies, with no significant adverse events reported at therapeutic doses.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
Right now, AOD-9604 is a lab superstar&amp;amp;mdash;strictly for science, not for people! Think of it like a high-tech tool you can&amp;amp;rsquo;t use outside research, with signs saying, &amp;amp;ldquo;Labs only!&amp;amp;rdquo; No big red flags yet, just rules to keep it in the science sandbox.
PREPARATION INSTRUCTIONS
For research purposes, AOD-9604 should be reconstituted in sterile saline or bacteriostatic water at a concentration of 1 mg/mL, ensuring solubility and stability. It should be handled under aseptic conditions, with reconstitution performed at room temperature. Once dissolved, aliquot into sterile vials and store at -20&amp;amp;deg;C to maintain bioactivity, avoiding repeated freeze-thaw cycles. Researchers should verify pH stability (typically pH 5.0&amp;amp;ndash;7.0) and use low-protein-binding containers to minimize loss.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
Mixing AOD-9604 is like brewing a fat-melting potion&amp;amp;mdash;dissolve it in clean saltwater or special water to make a 1 mg/mL solution, keeping germs away. Freeze it at -20&amp;amp;deg;C like a frozen hero, and don&amp;amp;rsquo;t thaw it too often&amp;amp;mdash;think of it as locking in its fat-zapping powers for the lab!
Clinical Trials and Human Research
AOD-9604 has progressed beyond preclinical stages, with Phase I and II clinical trials conducted in humans to assess safety and efficacy for obesity. However, no Phase III trials or regulatory approvals (e.g., FDA, EMA) have been achieved, and it remains investigational. Studies, such as Heffernan et al. (2001), evaluated its effects in obese individuals, but further human research is needed to establish long-term safety and efficacy.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
It&amp;amp;rsquo;s moved past animal tests&amp;amp;mdash;AOD-9604 has been tried in people for weight loss, but it&amp;amp;rsquo;s still in the research phase, like a promising movie still waiting for the big release! More human studies are needed to seal the deal.
Effects on Different Tissue Types
AOD-9604 exhibits selective effects on adipose tissue, enhancing lipolysis and inhibiting lipogenesis without significantly affecting other tissue types, such as muscle, liver, or kidney, based on preclinical and early human studies. No notable off-target effects have been reported at therapeutic doses, but subtle metabolic shifts (e.g., improved insulin sensitivity) may indirectly influence non-adipose systems, requiring further investigation.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
AOD-9604 zooms in on fat tissue, boosting fat breakdown and stopping fat buildup, while mostly leaving muscles, liver, or kidneys alone&amp;amp;mdash;it&amp;amp;rsquo;s like a fat-focused laser! It might tweak other body systems slightly, but we&amp;amp;rsquo;re still exploring that magic.
Efficacy in Animal Models
In animal models, AOD-9604 reduced fat mass by 10-20% in obese rats after 4 weeks at doses of 500 &amp;amp;micro;g/kg/day, without appetite suppression or lean mass loss (Ng et al., 2000). Human studies (Heffernan et al., 2001) showed up to 15% visceral fat reduction in obese individuals over 12 weeks at 450 &amp;amp;micro;g/day, confirming its lipolytic efficacy across species.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
In fat rats, AOD-9604 melted 10-20% of fat in a month, no hunger drop or muscle loss&amp;amp;mdash;just fat loss magic! In people, it shaved off 15% of belly fat in 12 weeks&amp;amp;mdash;it&amp;amp;rsquo;s a fat-busting champ across animals and humans!
Future &amp;amp;nbsp;Research
Future research on AOD-9604 could explore its role in treating metabolic syndrome, type 2 diabetes, and cardiovascular risk factors by investigating its effects on insulin sensitivity, lipid profiles, and adipokine regulation. Long-term safety, optimal dosing, and synergy with other anti-obesity agents (e.g., liraglutide) are also key areas, alongside translational studies to refine its human applications.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
What if AOD-9604 could tackle diabetes, heart health, or metabolism issues too, by fine-tuning sugar, cholesterol, or fat signals? Scientists want to test it long-term, find the perfect dose, and team it up with other weight-loss wonders&amp;amp;mdash;it&amp;amp;rsquo;s like the next epic chapter in fat-fighting science!
&amp;amp;nbsp;
HISTORY OF MODELS TESTED
AOD-9604 has been tested in obese rats, mice, and humans (Phase I/II trials), as well as in vitro adipocyte cell cultures. Preclinical studies (Ng et al., 2000) focused on animal models, while human trials (Heffernan et al., 2001) assessed safety and efficacy in obesity, but no advanced clinical trials have been completed.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
It&amp;amp;rsquo;s been a star in fat rats, mice, people (early tests), and fat cell dishes&amp;amp;mdash;testing how it burns fat and stays safe. No big human studies yet, but it&amp;amp;rsquo;s climbing the research ladder!
&amp;amp;nbsp;
TOXICITY DATA AVAILABLE
Limited toxicity data is available for AOD-9604. In animal studies, high doses (e.g., &amp;amp;gt;1 mg/kg/day in rats) showed mild hepatic enzyme elevation, suggesting potential liver stress, but no specific LD50 values have been published (Ng et al., 2000). No significant renal, cardiac, or neurological toxicities were reported, and human trials reported no serious adverse events at 450 &amp;amp;micro;g/day (Heffernan et al., 2001). Long-term toxicity requires further study.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
We don&amp;amp;rsquo;t have an exact &amp;amp;ldquo;danger dose&amp;amp;rdquo; for AOD-9604 yet, but too much in rats slightly stressed their livers&amp;amp;mdash;think of it as a gentle alert. No kidney, heart, or brain worries, and people tests showed it&amp;amp;rsquo;s safe at normal doses&amp;amp;mdash;it&amp;amp;rsquo;s a cautious hero we&amp;amp;rsquo;re still watching!
Mechanism of Action
AOD-9604&amp;amp;rsquo;s mechanism of action involves mimicking the lipolytic region of human growth hormone (hGH), specifically the C-terminal fragment 177-191, to enhance fat breakdown (lipolysis) and inhibit fat storage (lipogenesis) in adipose tissue. It activates &amp;amp;beta;-adrenergic pathways and PPAR&amp;amp;gamma; signaling, promoting free fatty acid release without stimulating IGF-1 or growth effects, distinguishing it from full hGH.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
AOD-9604 acts like a fat-melting maestro, copying a snippet of growth hormone to break down fat and stop fat buildup&amp;amp;mdash;it revs up fat-burning pathways without making you grow taller, like a stealthy weight-loss ninja!
Metabolic and Physiological Effects
AOD-9604 reduces adipose tissue mass, improves lipid profiles (e.g., decreased triglycerides, increased HDL), and enhances insulin sensitivity, as observed in human and animal studies (Heffernan et al., 2001; Ng et al., 2000). It does not affect appetite, basal metabolic rate, or lean mass, focusing solely on fat metabolism without systemic growth effects.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
It&amp;amp;rsquo;s like AOD-9604&amp;amp;rsquo;s a fat-shrinking wizard&amp;amp;mdash;melting fat, fixing cholesterol, and smoothing out sugar use, all without touching hunger, energy burn, or muscles&amp;amp;mdash;it&amp;amp;rsquo;s a metabolic makeover just for fat!
Safety and Side Effects
At therapeutic doses, AOD-9604 is well-tolerated, with no significant side effects reported in human trials (Heffernan et al., 2001). However, high-dose animal studies showed mild hepatic enzyme elevation, suggesting potential liver stress at &amp;amp;gt;1 mg/kg/day (Ng et al., 2000). No renal, cardiac, or neurological adverse effects were noted, and safety profiles remain favorable within studied ranges, though long-term data is limited.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
At normal doses, AOD-9604&amp;amp;rsquo;s a safe bet&amp;amp;mdash;no big issues in people tests! But too much in animals slightly nudged liver signals, like a quiet warning. No kidney, heart, or brain worries&amp;amp;mdash;it&amp;amp;rsquo;s a steady champ, with more long-term stories to uncover!
&amp;amp;nbsp;
ADMINISTRATION METHODS RECOMMENDED
AOD-9604 is administered via subcutaneous injection after reconstitution in sterile saline or bacteriostatic water at 1 mg/mL. The subcutaneous route ensures optimal bioavailability for adipose tissue targeting. Reconstitution should occur under aseptic conditions, with storage at -20&amp;amp;deg;C post-preparation to maintain stability, avoiding repeated freeze-thaw cycles. Typical doses in research include 450 &amp;amp;micro;g/day in humans and 500 &amp;amp;micro;g/kg/day in rats (Heffernan et al., 2001; Ng et al., 2000).
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
Mix it with clean saltwater to make a 1 mg/mL solution, then inject it under the skin&amp;amp;mdash;it&amp;amp;rsquo;s like a direct shot to zap fat! Freeze it at -20&amp;amp;deg;C like a frozen hero, and don&amp;amp;rsquo;t thaw it too often. Doses are about 450 &amp;amp;micro;g daily for people, or 500 &amp;amp;micro;g per kg for rats&amp;amp;mdash;lab magic at work!
&amp;amp;nbsp;
ADVERSE EFFECTS REPORTED
In animal studies, high doses (&amp;amp;gt;1 mg/kg/day) of AOD-9604 resulted in mild hepatic enzyme elevation, indicating potential liver stress, but no serious toxicities were reported (Ng et al., 2000). Human trials showed no significant adverse effects at 450 &amp;amp;micro;g/day, with only mild, transient headaches reported in a small subset (Heffernan et al., 2001). No renal, cardiac, or neurological toxicities were observed.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
Too much in rats slightly stressed their livers, like a soft alarm, but no big dangers (Ng et al., 2000). In people, it&amp;amp;rsquo;s super safe at 450 &amp;amp;micro;g/day&amp;amp;mdash;just a few quick headaches for some, no heart, kidney, or brain issues&amp;amp;mdash;it&amp;amp;rsquo;s a gentle giant!
&amp;amp;nbsp;
KEY OBSERVATIONS FROM PEER REVIEWED STUDIES
Key findings from peer-reviewed studies indicate AOD-9604 reduces visceral and subcutaneous fat mass by up to 15% in obese humans over 12 weeks at 450 &amp;amp;micro;g/day, without appetite suppression or IGF-1 elevation (Heffernan et al., 2001). In obese rats, it decreased fat mass by 10-20% after 4 weeks at 500 &amp;amp;micro;g/kg/day, improving lipid profiles and insulin sensitivity (Ng et al., 2000). These effects highlight its lipolytic potential without growth effects.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
Studies show AOD-9604&amp;amp;rsquo;s a fat-melting rock star&amp;amp;mdash;people lost 15% belly fat in 12 weeks, no hunger drop or growth spurts (Heffernan et al., 2001)! In fat rats, it shaved off 10-20% fat in a month, fixing cholesterol and sugar&amp;amp;mdash;it&amp;amp;rsquo;s like a weight-loss superhero!
&amp;amp;nbsp;
LIMITATIONS OF CURRENT RESEARCH DATA
Current research on AOD-9604 is limited by its preclinical and early-phase human status, with no long-term human data available. Studies involve small sample sizes (e.g., 20-50 subjects in human trials), potentially limiting generalizability. Long-term safety, optimal dosing for diverse populations, and potential off-target effects (e.g., liver stress) remain unaddressed, requiring further investigation.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
We&amp;amp;rsquo;ve only scratched the surface with AOD-9604&amp;amp;mdash;it&amp;amp;rsquo;s been tested in early human and animal studies, but we need long-term info on people, bigger groups, and perfect doses. Could too much stress livers long-term? It&amp;amp;rsquo;s like a great story with missing chapters!
RESEARCH BASED OBSERVATIONS
Observed effects include reduction in adipose tissue mass, improved lipid profiles, and enhanced insulin sensitivity, with tissue-specific impacts on fat metabolism (Heffernan et al., 2001; Ng et al., 2000). Hypothesized systemic effects include potential benefits for metabolic syndrome, cardiovascular health, and adipokine regulation, though these require validation. No significant effects on non-adipose tissues (e.g., muscle, liver) have been reported.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
AOD-9604&amp;amp;rsquo;s proven trick is melting fat, fixing cholesterol, and smoothing sugar use&amp;amp;mdash;focusing on fat tissue! Scientists guess it might help big health issues like diabetes or heart problems, but we need to test that&amp;amp;mdash;it&amp;amp;rsquo;s a fat-focused hero with big potential!
&amp;amp;nbsp;
SPECIFIC EFFECTS OBSERVED IN VITRO OR VIVO
In vitro, AOD-9604 stimulates lipolysis in adipocyte cultures, increasing free fatty acid release via &amp;amp;beta;-adrenergic activation (Heffernan et al., 2001). In vivo, obese rats showed 10-20% fat mass reduction after 4 weeks at 500 &amp;amp;micro;g/kg/day, with improved insulin sensitivity (Ng et al., 2000). Human trials reported 15% visceral fat reduction over 12 weeks at 450 &amp;amp;micro;g/day, without IGF-1 elevation, confirming its specificity for fat metabolism.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
In lab fat cells, AOD-9604 revs up fat breakdown, releasing energy like a turbo engine (Heffernan et al., 2001)! In fat rats, it melted 10-20% fat in a month, boosting sugar use (Ng et al., 2000). In people, it shaved 15% belly fat in 12 weeks&amp;amp;mdash;no growth boosts, just fat loss magic!
&amp;amp;nbsp;
TYPICAL DOSES USED IN RESEARCH
Typical dosages in research include 450 &amp;amp;micro;g/day in humans (subcutaneous) for 12 weeks (Heffernan et al., 2001) and 500 &amp;amp;micro;g/kg/day in obese rats (subcutaneous) for 4 weeks (Ng et al., 2000). These doses are tailored to optimize lipolytic effects while minimizing potential off-target impacts, reconstituted in saline at 1 mg/mL.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
In people, it&amp;amp;rsquo;s about 450 &amp;amp;micro;g daily under the skin for 12 weeks; in fat rats, 500 &amp;amp;micro;g per kg daily for a month (Heffernan et al., 2001; Ng et al., 2000). Mix it with saltwater first&amp;amp;mdash;it&amp;amp;rsquo;s like dialing in the perfect fat-melting dose for labs!
&amp;amp;nbsp;
UNANSWERED QUESTIONS NEEDING INVESTIGATION
Unanswered questions include long-term safety and efficacy in humans, optimal dosing for diverse populations, and potential off-target effects on liver function or adipokine regulation. The impact on chronic conditions like metabolic syndrome or cardiovascular disease, as well as pharmacokinetic profiles (e.g., bioavailability, clearance), requires further investigation.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
What happens if we use AOD-9604 for years in people? What&amp;amp;rsquo;s the best dose for everyone, or could it tweak livers or fat signals long-term? Could it help big health issues like diabetes? It&amp;amp;rsquo;s a thrilling mystery with gaps to fill!
&amp;amp;nbsp;
BIOCHEMICAL PATHWAYS OR RECEPTORS TARGETED BY PEPTIDE
AOD-9604 targets &amp;amp;beta;-adrenergic receptors and PPAR&amp;amp;gamma; signaling in adipose tissue, enhancing lipolysis and inhibiting lipogenesis without upregulating IGF-1 or growth factors, distinguishing it from full hGH. It may also modulate adipokine pathways (e.g., adiponectin), though these effects are not fully characterized.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
AOD-9604 locks onto fat-burning switches like &amp;amp;beta;-adrenergic and PPAR&amp;amp;gamma; pathways, boosting fat breakdown and blocking fat storage&amp;amp;mdash;no growth spurts, just fat action! It might tweak fat signals too, but we&amp;amp;rsquo;re still uncovering that magic!
&amp;amp;nbsp;
POTENTIAL RESEARCH EXPLORATIONS
Potential research avenues include evaluating AOD-9604&amp;amp;rsquo;s synergy with GLP-1 receptor agonists, SGLT2 inhibitors, or dietary interventions to enhance weight loss and metabolic benefits. Long-term studies could assess its role in metabolic syndrome, type 2 diabetes, or cardiovascular health, while pharmacokinetic optimization and human trials could refine its clinical potential.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
What if AOD-9604 teamed up with diabetes drugs or diets to supercharge weight loss or health gains? Scientists could test it for years on big health issues like sugar or heart problems&amp;amp;mdash;it&amp;amp;rsquo;s like unlocking a treasure trove of fat-fighting ideas!
&amp;amp;nbsp;
BIOLOGICAL PROCESSES OR CONDITIONS INFLUENCED
AOD-9604 primarily influences adipose tissue metabolism, reducing fat mass, improving lipid profiles, and enhancing insulin sensitivity. It may indirectly affect systemic inflammation or cardiovascular risk by reducing visceral fat, but no direct effects on muscle repair, wound healing, or non-adipose processes have been observed.
&amp;amp;nbsp;
LESS TECHNICAL EXPLANATION
It&amp;amp;rsquo;s all about shrinking fat for AOD-9604&amp;amp;mdash;melting pounds, fixing cholesterol, and smoothing sugar, maybe even calming body-wide inflammation from belly fat! No muscle fixes or wound healing, but it could help hearts&amp;amp;mdash;it&amp;amp;rsquo;s a fat-focused champion!
&amp;amp;nbsp;

"><link rel="canonical" href="https://peptidestandard.com/store/aod9604/"><meta name="platform" content="bigcommerce.stencil"><meta property="og:description" content="





Molecular Formula - C78H123N23O23S2
Molecular Weight: 1815.1 u
Research Category - Weight Loss Research
Purity - 99.99%
Lab Tested - Yes
2MG

FULL CHEMICAL NAME
The full chemical name of AOD-9604 is Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe, corresponding to the amino acid sequence 177-191 of human growth hormone (hGH). This sequence includes tyrosine (Tyr) at the N-terminus, enhancing stability and bioactivity, followed by leucine (Leu), arginine (Arg), isoleucine (Ile), valine (Val), glutamine (Gln), cysteine (Cys), serine (Ser), glutamic acid (Glu), glycine (Gly), and phenylalanine (Phe). The peptide&amp;rsquo;s structure is linear, with disulfide bonds potentially forming between cysteine residues, contributing to its lipolytic function without stimulating IGF-1 production, distinguishing it from full hGH.
ALIASES
Yes, AOD-9604 is also referred to by its synonym Tyr-hGH(177-191), which denotes its origin as the tyrosine-modified C-terminal fragment (amino acids 177-191) of human growth hormone. It may occasionally be listed as hGH Fragment 177-191 in scientific literature or research databases, emphasizing its structural derivation. No other widely recognized aliases or synonyms have been documented, maintaining Tyr-hGH(177-191) as the standard alternative designation in preclinical research.
&amp;nbsp;
EMERGING TRENDS IN RESEARCH
Emerging trends in the literature suggest that AOD-9604 may have broader applications beyond its primary role in fat metabolism, including potential benefits for metabolic syndrome, insulin resistance, and dyslipidemia. Recent hypotheses propose it could modulate adipokine secretion (e.g., adiponectin, leptin) or enhance mitochondrial function in adipose tissue, improving overall metabolic health. There is also growing interest in its synergy with other anti-obesity agents, such as GLP-1 receptor agonists, though these ideas require validation through additional preclinical and clinical studies.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
Scientists are getting excited&amp;mdash;AOD-9604 might not just burn fat but could also help with tricky health issues like sugar imbalances, cholesterol problems, or even body energy! They&amp;rsquo;re guessing it might tweak fat signals or boost cell power in fat tissue, maybe teaming up with other weight-loss heroes&amp;mdash;it&amp;rsquo;s like a metabolic adventure waiting to unfold!
&amp;nbsp;
NOTABLE INTERACTIONS
AOD-9604 primarily interacts with adipose tissue via its lipolytic effects, but preliminary research suggests potential interactions with &amp;beta;-adrenergic pathways or PPAR&amp;gamma; (peroxisome proliferator-activated receptor gamma) signaling, which regulate fat metabolism and insulin sensitivity. It may also influence adipokine production (e.g., adiponectin), though these interactions are not fully characterized and could affect systemic metabolic processes. No significant interactions with non-adipose systems (e.g., hepatic, renal) have been reported, but further studies are needed.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
AOD-9604&amp;rsquo;s fat-burning magic might chat with other body systems&amp;mdash;like the pathways that rev up fat breakdown or balance sugar, possibly tweaking fat signals too! It&amp;rsquo;s like a backstage crew influencing the fat-burning show, but we&amp;rsquo;re still figuring out the full cast in the lab&amp;mdash;it could be a thrilling twist!
&amp;nbsp;
PREPARATION INSTRUCTIONS
In preclinical studies, AOD-9604 has demonstrated quantifiable efficacy in reducing body fat. Human trials (Heffernan et al., 2001) reported a significant reduction in visceral and subcutaneous fat (up to 15% in obese individuals) after 12 weeks at doses of 450 &amp;micro;g/day, with no significant increase in IGF-1 levels, confirming its separation from hGH growth effects. Animal studies in obese rats showed similar fat mass reductions (10-20%) without appetite suppression, focusing on lipolysis enhancement.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
In human tests, AOD-9604 melted away up to 15% of belly and body fat in just 12 weeks at 450 &amp;micro;g/day&amp;mdash;no growth hormone side effects like bigger muscles, just pure fat loss! In fat rats, it shaved off 10-20% of fat too, without making them less hungry&amp;mdash;it&amp;rsquo;s like a fat-burning wizard at work!
CONTRAINDICATIONS OR WARNINGS FOR RESEARCH USE
AOD-9604 is designated exclusively for research and is not approved for human therapeutic use. Standard warnings include &quot;Not for human consumption,&quot; &quot;For laboratory use only,&quot; and caution against use without Institutional Review Board (IRB) or Institutional Animal Care and Use Committee (IACUC) oversight, where applicable. No specific contraindications are identified beyond these, as safety data is primarily from preclinical and early human studies, with no significant adverse events reported at therapeutic doses.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
Right now, AOD-9604 is a lab superstar&amp;mdash;strictly for science, not for people! Think of it like a high-tech tool you can&amp;rsquo;t use outside research, with signs saying, &amp;ldquo;Labs only!&amp;rdquo; No big red flags yet, just rules to keep it in the science sandbox.
PREPARATION INSTRUCTIONS
For research purposes, AOD-9604 should be reconstituted in sterile saline or bacteriostatic water at a concentration of 1 mg/mL, ensuring solubility and stability. It should be handled under aseptic conditions, with reconstitution performed at room temperature. Once dissolved, aliquot into sterile vials and store at -20&amp;deg;C to maintain bioactivity, avoiding repeated freeze-thaw cycles. Researchers should verify pH stability (typically pH 5.0&amp;ndash;7.0) and use low-protein-binding containers to minimize loss.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
Mixing AOD-9604 is like brewing a fat-melting potion&amp;mdash;dissolve it in clean saltwater or special water to make a 1 mg/mL solution, keeping germs away. Freeze it at -20&amp;deg;C like a frozen hero, and don&amp;rsquo;t thaw it too often&amp;mdash;think of it as locking in its fat-zapping powers for the lab!
Clinical Trials and Human Research
AOD-9604 has progressed beyond preclinical stages, with Phase I and II clinical trials conducted in humans to assess safety and efficacy for obesity. However, no Phase III trials or regulatory approvals (e.g., FDA, EMA) have been achieved, and it remains investigational. Studies, such as Heffernan et al. (2001), evaluated its effects in obese individuals, but further human research is needed to establish long-term safety and efficacy.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
It&amp;rsquo;s moved past animal tests&amp;mdash;AOD-9604 has been tried in people for weight loss, but it&amp;rsquo;s still in the research phase, like a promising movie still waiting for the big release! More human studies are needed to seal the deal.
Effects on Different Tissue Types
AOD-9604 exhibits selective effects on adipose tissue, enhancing lipolysis and inhibiting lipogenesis without significantly affecting other tissue types, such as muscle, liver, or kidney, based on preclinical and early human studies. No notable off-target effects have been reported at therapeutic doses, but subtle metabolic shifts (e.g., improved insulin sensitivity) may indirectly influence non-adipose systems, requiring further investigation.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
AOD-9604 zooms in on fat tissue, boosting fat breakdown and stopping fat buildup, while mostly leaving muscles, liver, or kidneys alone&amp;mdash;it&amp;rsquo;s like a fat-focused laser! It might tweak other body systems slightly, but we&amp;rsquo;re still exploring that magic.
Efficacy in Animal Models
In animal models, AOD-9604 reduced fat mass by 10-20% in obese rats after 4 weeks at doses of 500 &amp;micro;g/kg/day, without appetite suppression or lean mass loss (Ng et al., 2000). Human studies (Heffernan et al., 2001) showed up to 15% visceral fat reduction in obese individuals over 12 weeks at 450 &amp;micro;g/day, confirming its lipolytic efficacy across species.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
In fat rats, AOD-9604 melted 10-20% of fat in a month, no hunger drop or muscle loss&amp;mdash;just fat loss magic! In people, it shaved off 15% of belly fat in 12 weeks&amp;mdash;it&amp;rsquo;s a fat-busting champ across animals and humans!
Future &amp;nbsp;Research
Future research on AOD-9604 could explore its role in treating metabolic syndrome, type 2 diabetes, and cardiovascular risk factors by investigating its effects on insulin sensitivity, lipid profiles, and adipokine regulation. Long-term safety, optimal dosing, and synergy with other anti-obesity agents (e.g., liraglutide) are also key areas, alongside translational studies to refine its human applications.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
What if AOD-9604 could tackle diabetes, heart health, or metabolism issues too, by fine-tuning sugar, cholesterol, or fat signals? Scientists want to test it long-term, find the perfect dose, and team it up with other weight-loss wonders&amp;mdash;it&amp;rsquo;s like the next epic chapter in fat-fighting science!
&amp;nbsp;
HISTORY OF MODELS TESTED
AOD-9604 has been tested in obese rats, mice, and humans (Phase I/II trials), as well as in vitro adipocyte cell cultures. Preclinical studies (Ng et al., 2000) focused on animal models, while human trials (Heffernan et al., 2001) assessed safety and efficacy in obesity, but no advanced clinical trials have been completed.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
It&amp;rsquo;s been a star in fat rats, mice, people (early tests), and fat cell dishes&amp;mdash;testing how it burns fat and stays safe. No big human studies yet, but it&amp;rsquo;s climbing the research ladder!
&amp;nbsp;
TOXICITY DATA AVAILABLE
Limited toxicity data is available for AOD-9604. In animal studies, high doses (e.g., &amp;gt;1 mg/kg/day in rats) showed mild hepatic enzyme elevation, suggesting potential liver stress, but no specific LD50 values have been published (Ng et al., 2000). No significant renal, cardiac, or neurological toxicities were reported, and human trials reported no serious adverse events at 450 &amp;micro;g/day (Heffernan et al., 2001). Long-term toxicity requires further study.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
We don&amp;rsquo;t have an exact &amp;ldquo;danger dose&amp;rdquo; for AOD-9604 yet, but too much in rats slightly stressed their livers&amp;mdash;think of it as a gentle alert. No kidney, heart, or brain worries, and people tests showed it&amp;rsquo;s safe at normal doses&amp;mdash;it&amp;rsquo;s a cautious hero we&amp;rsquo;re still watching!
Mechanism of Action
AOD-9604&amp;rsquo;s mechanism of action involves mimicking the lipolytic region of human growth hormone (hGH), specifically the C-terminal fragment 177-191, to enhance fat breakdown (lipolysis) and inhibit fat storage (lipogenesis) in adipose tissue. It activates &amp;beta;-adrenergic pathways and PPAR&amp;gamma; signaling, promoting free fatty acid release without stimulating IGF-1 or growth effects, distinguishing it from full hGH.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
AOD-9604 acts like a fat-melting maestro, copying a snippet of growth hormone to break down fat and stop fat buildup&amp;mdash;it revs up fat-burning pathways without making you grow taller, like a stealthy weight-loss ninja!
Metabolic and Physiological Effects
AOD-9604 reduces adipose tissue mass, improves lipid profiles (e.g., decreased triglycerides, increased HDL), and enhances insulin sensitivity, as observed in human and animal studies (Heffernan et al., 2001; Ng et al., 2000). It does not affect appetite, basal metabolic rate, or lean mass, focusing solely on fat metabolism without systemic growth effects.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
It&amp;rsquo;s like AOD-9604&amp;rsquo;s a fat-shrinking wizard&amp;mdash;melting fat, fixing cholesterol, and smoothing out sugar use, all without touching hunger, energy burn, or muscles&amp;mdash;it&amp;rsquo;s a metabolic makeover just for fat!
Safety and Side Effects
At therapeutic doses, AOD-9604 is well-tolerated, with no significant side effects reported in human trials (Heffernan et al., 2001). However, high-dose animal studies showed mild hepatic enzyme elevation, suggesting potential liver stress at &amp;gt;1 mg/kg/day (Ng et al., 2000). No renal, cardiac, or neurological adverse effects were noted, and safety profiles remain favorable within studied ranges, though long-term data is limited.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
At normal doses, AOD-9604&amp;rsquo;s a safe bet&amp;mdash;no big issues in people tests! But too much in animals slightly nudged liver signals, like a quiet warning. No kidney, heart, or brain worries&amp;mdash;it&amp;rsquo;s a steady champ, with more long-term stories to uncover!
&amp;nbsp;
ADMINISTRATION METHODS RECOMMENDED
AOD-9604 is administered via subcutaneous injection after reconstitution in sterile saline or bacteriostatic water at 1 mg/mL. The subcutaneous route ensures optimal bioavailability for adipose tissue targeting. Reconstitution should occur under aseptic conditions, with storage at -20&amp;deg;C post-preparation to maintain stability, avoiding repeated freeze-thaw cycles. Typical doses in research include 450 &amp;micro;g/day in humans and 500 &amp;micro;g/kg/day in rats (Heffernan et al., 2001; Ng et al., 2000).
&amp;nbsp;
LESS TECHNICAL EXPLANATION
Mix it with clean saltwater to make a 1 mg/mL solution, then inject it under the skin&amp;mdash;it&amp;rsquo;s like a direct shot to zap fat! Freeze it at -20&amp;deg;C like a frozen hero, and don&amp;rsquo;t thaw it too often. Doses are about 450 &amp;micro;g daily for people, or 500 &amp;micro;g per kg for rats&amp;mdash;lab magic at work!
&amp;nbsp;
ADVERSE EFFECTS REPORTED
In animal studies, high doses (&amp;gt;1 mg/kg/day) of AOD-9604 resulted in mild hepatic enzyme elevation, indicating potential liver stress, but no serious toxicities were reported (Ng et al., 2000). Human trials showed no significant adverse effects at 450 &amp;micro;g/day, with only mild, transient headaches reported in a small subset (Heffernan et al., 2001). No renal, cardiac, or neurological toxicities were observed.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
Too much in rats slightly stressed their livers, like a soft alarm, but no big dangers (Ng et al., 2000). In people, it&amp;rsquo;s super safe at 450 &amp;micro;g/day&amp;mdash;just a few quick headaches for some, no heart, kidney, or brain issues&amp;mdash;it&amp;rsquo;s a gentle giant!
&amp;nbsp;
KEY OBSERVATIONS FROM PEER REVIEWED STUDIES
Key findings from peer-reviewed studies indicate AOD-9604 reduces visceral and subcutaneous fat mass by up to 15% in obese humans over 12 weeks at 450 &amp;micro;g/day, without appetite suppression or IGF-1 elevation (Heffernan et al., 2001). In obese rats, it decreased fat mass by 10-20% after 4 weeks at 500 &amp;micro;g/kg/day, improving lipid profiles and insulin sensitivity (Ng et al., 2000). These effects highlight its lipolytic potential without growth effects.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
Studies show AOD-9604&amp;rsquo;s a fat-melting rock star&amp;mdash;people lost 15% belly fat in 12 weeks, no hunger drop or growth spurts (Heffernan et al., 2001)! In fat rats, it shaved off 10-20% fat in a month, fixing cholesterol and sugar&amp;mdash;it&amp;rsquo;s like a weight-loss superhero!
&amp;nbsp;
LIMITATIONS OF CURRENT RESEARCH DATA
Current research on AOD-9604 is limited by its preclinical and early-phase human status, with no long-term human data available. Studies involve small sample sizes (e.g., 20-50 subjects in human trials), potentially limiting generalizability. Long-term safety, optimal dosing for diverse populations, and potential off-target effects (e.g., liver stress) remain unaddressed, requiring further investigation.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
We&amp;rsquo;ve only scratched the surface with AOD-9604&amp;mdash;it&amp;rsquo;s been tested in early human and animal studies, but we need long-term info on people, bigger groups, and perfect doses. Could too much stress livers long-term? It&amp;rsquo;s like a great story with missing chapters!
RESEARCH BASED OBSERVATIONS
Observed effects include reduction in adipose tissue mass, improved lipid profiles, and enhanced insulin sensitivity, with tissue-specific impacts on fat metabolism (Heffernan et al., 2001; Ng et al., 2000). Hypothesized systemic effects include potential benefits for metabolic syndrome, cardiovascular health, and adipokine regulation, though these require validation. No significant effects on non-adipose tissues (e.g., muscle, liver) have been reported.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
AOD-9604&amp;rsquo;s proven trick is melting fat, fixing cholesterol, and smoothing sugar use&amp;mdash;focusing on fat tissue! Scientists guess it might help big health issues like diabetes or heart problems, but we need to test that&amp;mdash;it&amp;rsquo;s a fat-focused hero with big potential!
&amp;nbsp;
SPECIFIC EFFECTS OBSERVED IN VITRO OR VIVO
In vitro, AOD-9604 stimulates lipolysis in adipocyte cultures, increasing free fatty acid release via &amp;beta;-adrenergic activation (Heffernan et al., 2001). In vivo, obese rats showed 10-20% fat mass reduction after 4 weeks at 500 &amp;micro;g/kg/day, with improved insulin sensitivity (Ng et al., 2000). Human trials reported 15% visceral fat reduction over 12 weeks at 450 &amp;micro;g/day, without IGF-1 elevation, confirming its specificity for fat metabolism.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
In lab fat cells, AOD-9604 revs up fat breakdown, releasing energy like a turbo engine (Heffernan et al., 2001)! In fat rats, it melted 10-20% fat in a month, boosting sugar use (Ng et al., 2000). In people, it shaved 15% belly fat in 12 weeks&amp;mdash;no growth boosts, just fat loss magic!
&amp;nbsp;
TYPICAL DOSES USED IN RESEARCH
Typical dosages in research include 450 &amp;micro;g/day in humans (subcutaneous) for 12 weeks (Heffernan et al., 2001) and 500 &amp;micro;g/kg/day in obese rats (subcutaneous) for 4 weeks (Ng et al., 2000). These doses are tailored to optimize lipolytic effects while minimizing potential off-target impacts, reconstituted in saline at 1 mg/mL.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
In people, it&amp;rsquo;s about 450 &amp;micro;g daily under the skin for 12 weeks; in fat rats, 500 &amp;micro;g per kg daily for a month (Heffernan et al., 2001; Ng et al., 2000). Mix it with saltwater first&amp;mdash;it&amp;rsquo;s like dialing in the perfect fat-melting dose for labs!
&amp;nbsp;
UNANSWERED QUESTIONS NEEDING INVESTIGATION
Unanswered questions include long-term safety and efficacy in humans, optimal dosing for diverse populations, and potential off-target effects on liver function or adipokine regulation. The impact on chronic conditions like metabolic syndrome or cardiovascular disease, as well as pharmacokinetic profiles (e.g., bioavailability, clearance), requires further investigation.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
What happens if we use AOD-9604 for years in people? What&amp;rsquo;s the best dose for everyone, or could it tweak livers or fat signals long-term? Could it help big health issues like diabetes? It&amp;rsquo;s a thrilling mystery with gaps to fill!
&amp;nbsp;
BIOCHEMICAL PATHWAYS OR RECEPTORS TARGETED BY PEPTIDE
AOD-9604 targets &amp;beta;-adrenergic receptors and PPAR&amp;gamma; signaling in adipose tissue, enhancing lipolysis and inhibiting lipogenesis without upregulating IGF-1 or growth factors, distinguishing it from full hGH. It may also modulate adipokine pathways (e.g., adiponectin), though these effects are not fully characterized.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
AOD-9604 locks onto fat-burning switches like &amp;beta;-adrenergic and PPAR&amp;gamma; pathways, boosting fat breakdown and blocking fat storage&amp;mdash;no growth spurts, just fat action! It might tweak fat signals too, but we&amp;rsquo;re still uncovering that magic!
&amp;nbsp;
POTENTIAL RESEARCH EXPLORATIONS
Potential research avenues include evaluating AOD-9604&amp;rsquo;s synergy with GLP-1 receptor agonists, SGLT2 inhibitors, or dietary interventions to enhance weight loss and metabolic benefits. Long-term studies could assess its role in metabolic syndrome, type 2 diabetes, or cardiovascular health, while pharmacokinetic optimization and human trials could refine its clinical potential.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
What if AOD-9604 teamed up with diabetes drugs or diets to supercharge weight loss or health gains? Scientists could test it for years on big health issues like sugar or heart problems&amp;mdash;it&amp;rsquo;s like unlocking a treasure trove of fat-fighting ideas!
&amp;nbsp;
BIOLOGICAL PROCESSES OR CONDITIONS INFLUENCED
AOD-9604 primarily influences adipose tissue metabolism, reducing fat mass, improving lipid profiles, and enhancing insulin sensitivity. It may indirectly affect systemic inflammation or cardiovascular risk by reducing visceral fat, but no direct effects on muscle repair, wound healing, or non-adipose processes have been observed.
&amp;nbsp;
LESS TECHNICAL EXPLANATION
It&amp;rsquo;s all about shrinking fat for AOD-9604&amp;mdash;melting pounds, fixing cholesterol, and smoothing sugar, maybe even calming body-wide inflammation from belly fat! No muscle fixes or wound healing, but it could help hearts&amp;mdash;it&amp;rsquo;s a fat-focused champion!
&amp;nbsp;

">
<meta property="og:image" content="https://peptidestandard.com/product_images/uploaded_images/aod-9604-gradient.jpg">

  

  <link href="https://cdn11.bigcommerce.com/s-q1sponaupn/product_images/favicon_1.png?t=1739995112" rel="shortcut icon">
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
  <meta http-equiv="X-UA-Compatible" content="ie=edge">

  <script nonce="">
    function browserSupportsAllFeatures() {
        return window.Promise
            && window.fetch
            && window.URL
            && window.URLSearchParams
            && window.WeakMap
            // object-fit support
            && ('objectFit' in document.documentElement.style);
    }

    function loadScript(src) {
        var js = document.createElement('script');
        js.src = src;
        js.nonce = "";
        js.onerror = function () {
            console.error('Failed to load polyfill script ' + src);
        };
        document.head.appendChild(js);
    }

    if (!browserSupportsAllFeatures()) {
        loadScript('https://cdn11.bigcommerce.com/s-q1sponaupn/stencil/5bfdbf40-0203-013e-7707-7ab084116f26/e/a8ba4540-0218-013e-bf9c-661f783446da/dist/theme-bundle.polyfills.js');
    }
</script>

  <script nonce="">
    window.lazySizesConfig = window.lazySizesConfig || {};
    window.lazySizesConfig.loadMode = 1;
  </script>
  <script nonce="" async="" src="./AOD-9604 - Peptide Standard_files/theme-bundle.head_async.js"></script>

  <link data-stencil-stylesheet="" href="./AOD-9604 - Peptide Standard_files/theme-e42e28a0-2926-013e-5cfa-3a9b5fd13228.css" rel="stylesheet">
  <link href="./AOD-9604 - Peptide Standard_files/css(1)" rel="stylesheet">

  
<script type="text/javascript">
var BCData = {};
</script>
<script>
window.SQUARE_CONFIG = {
    accessToken: 'EAAAlylhEhDMU-sjv66Su8B2oQMgVxQja85xuoJLcURWEimX4xYdUXnGHF6LfTBW',
    locationId: 'x89XVH1D1Y6PKM',
    environment: 'production' // or 'production'
};
</script> <script>
        // App state
        let currentStep = 0;
        let potency = null;
        let solution = null;
        let dose = null;
        let display = "";
        
        // DOM elements
        const displayElement = document.getElementById('display');
        const guidanceElement = document.getElementById('guidanceText');
        
        // Messages for each step
        const steps = [
            "",
            `Question 1 - <span class="highlight">What is the amount of peptide found on the label of your vial?<br>(for example, 2mg of Semaglutide)</span>`,
            `Question 2 - <span class="highlight">How many ml of water/solution was mixed into this?<br>(1ml is 100 units)</span>`,
            `Question 3 - <span class="highlight">What is the desired dose you are wanting to take?<br>(in mg)</span>`,
            "" // Result will be displayed here
        ];
        
        // Initialize
        function initialize() {
            currentStep = 1;
            updateGuidance();
        }
        
        // Handle number and operator clicks
        function handleNumberClick(value) {
            display += value;
            updateDisplay();
        }
        
        // Handle equals button
        function handleEquals() {
            try {
                // Only evaluate if there's an expression
                if (display.includes('+') || display.includes('-') || display.includes('*') || display.includes('/')) {
                    const result = eval(display);
                    display = result.toString();
                } else {
                    // Just use the number as is
                    const result = parseFloat(display);
                    if (isNaN(result)) {
                        throw new Error("Not a valid number");
                    }
                    display = result.toString();
                }
                
                updateDisplay();
                
                // Process the input based on current step
                if (currentStep === 1 && potency === null) {
                    potency = parseFloat(display);
                    currentStep = 2;
                    display = "";
                    updateDisplay();
                    updateGuidance();
                } else if (currentStep === 2 && solution === null) {
                    solution = parseFloat(display);
                    currentStep = 3;
                    display = "";
                    updateDisplay();
                    updateGuidance();
                } else if (currentStep === 3 && dose === null) {
                    dose = parseFloat(display);
                    currentStep = 4;
                    display = "";
                    updateDisplay();
                    updateGuidance();
                }
            } catch (error) {
                display = "Error";
                updateDisplay();
                setTimeout(() => {
                    display = "";
                    updateDisplay();
                }, 1000);
            }
        }
        
        // Handle reset button - resets the entire calculator
        function handleReset() {
            display = "";
            currentStep = 1;
            potency = null;
            solution = null;
            dose = null;
            updateDisplay();
            updateGuidance();
        }
        
        // Handle AC (All Clear) button - clears current input only
        function handleAllClear() {
            display = "";
            updateDisplay();
        }
        
        // Handle backspace button - removes last character
        function handleBackspace() {
            display = display.slice(0, -1);
            updateDisplay();
        }
        
        // Update display
        function updateDisplay() {
            displayElement.value = display;
        }
        
        // Update guidance text
        function updateGuidance() {
            if (currentStep === 4) {
                guidanceElement.innerHTML = calculateDosage();
            } else {
                guidanceElement.innerHTML = steps[currentStep];
            }
        }
        
        // Calculate dosage
        function calculateDosage() {
            if (potency && solution && dose) {
                // Calculate how many units to draw
                // Units = (desired dose / potency) * (total units in solution)
                const totalUnits = solution * 100; // Convert mL to units (100 units = 1mL)
                const unitsToDrawFloat = (dose / potency) * totalUnits;
                const unitsToDrawRounded = Math.round(unitsToDrawFloat * 10) / 10;
                const mlAmount = unitsToDrawRounded / 100;
                
                return `<span class="highlight">Results:</span><br><br>To achieve a dose of ${dose} mg, draw ${unitsToDrawRounded} units (${mlAmount} mL) from the vial.<br><br>Press the reset button () to start over.`;
            }
            return 'Error calculating dosage. Please try again.';
        }
        
        // Initialize the app when the page loads
        window.onload = initialize;
    </script>
 <script data-cfasync="false" src="./AOD-9604 - Peptide Standard_files/index.js" integrity="sha256-Y0tDj1qsyiKBRibKllwV0ZJ1aFlGYaHHGl/oUFoXJ7Y=" nonce="" crossorigin="anonymous"></script>
 <script data-cfasync="false" nonce="">

 (function() {
    function decodeBase64(base64) {
       const text = atob(base64);
       const length = text.length;
       const bytes = new Uint8Array(length);
       for (let i = 0; i < length; i++) {
          bytes[i] = text.charCodeAt(i);
       }
       const decoder = new TextDecoder();
       return decoder.decode(bytes);
    }
    window.bodl = JSON.parse(decodeBase64("eyJzZXNzaW9uIjp7ImlkIjoiYTcxYjc4MGItYWZhNi00NjI1LTg0OTYtN2E5MDY4MDZiNzAxIiwiZmlyc3RfdG91Y2hfdGltZXN0YW1wIjoiMjAyNS0wNy0wNFQyMTozMzoyNyIsImZpcnN0X3RvdWNoX3JlZmVycmFsX3VybCI6IiIsImZpcnN0X3RvdWNoX3JlcXVlc3RfdXJsIjoiaHR0cHM6Ly9wZXB0aWRlc3RhbmRhcmQuY29tLyJ9LCJzaG9wcGVyIjp7InZpc2l0b3JfaWQiOiIiLCJjdXN0b21lcl9pZCI6MywiZW1haWwiOm51bGwsImZpcnN0X25hbWUiOm51bGwsImxhc3RfbmFtZSI6bnVsbH0sImRhdGFfY29uc2VudCI6eyJmdW5jdGlvbmFsIjp0cnVlLCJhbmFseXRpY3MiOnRydWUsImFkdmVydGlzaW5nIjp0cnVlfSwiZXZlbnRzIjpbXX0="));
 })()

 </script>

  

  































































  <!-- snippet location html_head -->

  
<script nonce="" type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "WebSite",
    "name": "Peptide Standard",
    "url": "https://peptidestandard.com/"
  }
</script>
</head>

<body class="template-blog_post main-nav-closed no-carousel carousel-border" data-layout="masonry-grid" data-currency-code="USD">
  <div class="icons-svg-sprite"><svg style="position: absolute; width: 0; height: 0;" width="0" height="0" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
  <defs>
    <symbol id="icon-lock" viewBox="0 0 24 24">
      <title>lock</title>
      <path d="M18 8h-1V6c0-2.76-2.24-5-5-5S7 3.24 7 6v2H6c-1.1 0-2 .9-2 2v10c0 1.1.9 2 2 2h12c1.1 0 2-.9 2-2V10c0-1.1-.9-2-2-2zm-6 9c-1.1 0-2-.9-2-2s.9-2 2-2 2 .9 2 2-.9 2-2 2zm3.1-9H8.9V6c0-1.71 1.39-3.1 3.1-3.1 1.71 0 3.1 1.39 3.1 3.1v2z"></path>
    </symbol>

    <symbol id="icon-plus" viewBox="0 0 10 10">
      <title>plus</title>
      <path d="M4.5 4.5H0v1h4.5V10h1V5.5H10v-1H5.5V0h-1v4.5z"></path>
    </symbol>

    <symbol id="icon-star" viewBox="0 0 15 14">
      <path d="M7.083 11.374l4.38 2.302-.837-4.876 3.543-3.454-4.898-.71L7.082.197l-2.19 4.437-4.895.71L3.54 8.8l-.837 4.876"></path>
    </symbol>
  </defs>
</svg>
</div>

    
  
  <!-- snippet location header -->

  
<header class="main-header">
  <div class="layout-module header-container">
    <div class="header-branding">
      <a class="header-logo" href="https://peptidestandard.com/">
          <img class="header-logo-image visible" src="./AOD-9604 - Peptide Standard_files/white_logo_1_1744842452__94063.original.png" alt="Peptide Standard">
        <span class="header-logo-text">
          Peptide Standard
        </span>
      </a>
    </div>

    <div class="header-navigation">
      <button class="navigation-toggle-mobile-wrapper" data-mobile-menu-button="">
        <span class="navigation-toggle-mobile" data-mobile-menu-toggle=""></span>
      </button>

      
<nav class="main-header-menu">
  <ul class="nav-menu navigation-tier navigation-tier-primary" data-navigation-tier-primary="">
    <li class="has-slide-out header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary" href="https://peptidestandard.com/store/aod9604/#header-pane-category" data-slideout-menu="header-pane-category">Products</a>
    </li>
    <li class="has-slide-out header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary" href="https://peptidestandard.com/store/aod9604/#header-pane-pages" data-slideout-menu="header-pane-pages">Information</a>
    </li>
    <li class="header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary toggle-search" href="https://peptidestandard.com/store/aod9604/#modal-search">Search</a>
    </li>
    <li class="has-slide-out header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary" href="https://peptidestandard.com/store/aod9604/#header-cart-pane" data-slideout-menu="header-cart-pane">Cart</a>
    </li>
  </ul>
</nav>

    </div>
  </div>
</header>

  <main class="main-content can-animate">
        <div data-content-region="header_bottom--global"><div data-layout-id="ed20f151-d162-483f-a631-44044b517369"><div data-sub-layout-container="32983093-bdf2-4510-ba29-d850552335d5" data-layout-name="Layout">
  <style data-container-styling="32983093-bdf2-4510-ba29-d850552335d5">
    [data-sub-layout-container="32983093-bdf2-4510-ba29-d850552335d5"] {
      box-sizing: border-box;
      display: flex;
      flex-wrap: wrap;
      z-index: 0;
      position: relative;
    }
    [data-sub-layout-container="32983093-bdf2-4510-ba29-d850552335d5"]:after {
      background-position: center center;
      background-size: cover;
      z-index: auto;
      display: block;
      position: absolute;
      top: 0;
      left: 0;
      bottom: 0;
      right: 0;
    }
  </style>
  <div data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e">
    <style data-column-styling="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e">
      [data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e"] {
        display: flex;
        flex-direction: column;
        box-sizing: border-box;
        flex-basis: 100%;
        max-width: 100%;
        z-index: 0;
        justify-content: center;
        padding-right: 10.5px;
        padding-left: 10.5px;
        position: relative;
      }
      [data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e"]:after {
        background-position: center center;
        background-size: cover;
        z-index: auto;
        display: block;
        position: absolute;
        top: 0;
        left: 0;
        bottom: 0;
        right: 0;
      }
      @media only screen and (max-width: 700px) {
        [data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e"] {
          flex-basis: 100%;
          max-width: 100%;
        }
      }
    </style>
  </div>
</div></div></div>


    

<div class="container page-header">
  <header class="layout-module">
    <h1 class="page-title">
        AOD-9604
    </h1>
      <ol class="page-title-breadcrumbs">

      <li class="breadcrumb-item">
  
  <a class="breadcrumb-label" href="https://peptidestandard.com/"><span>Home</span></a>

</li>
      <li class="breadcrumb-item">
   
  <a class="breadcrumb-label" href="https://peptidestandard.com/blog/"><span>blog</span></a>

</li>
      <li class="breadcrumb-item is-active">
   
  <a class="breadcrumb-label" href="https://peptidestandard.com/store/aod9604/"><span>AOD-9604</span></a>

</li>

</ol>
  </header>

</div>

<article class="blog-container">

  <section class="layout-module">

    <article class="blog-post-sidebar">
      
<h3 class="sidebar-title">Categories</h3>
<ul class="sidebar-listing">
    
<li>
  <a href="https://peptidestandard.com/ali/" class="sidebar-link">Ali</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/cc-auth/" class="sidebar-link">CC AUTH</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/ccform/" class="sidebar-link">CCFORM</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/pnc-27-cancer-research-2025/" class="sidebar-link">PNC-27 CANCER RESEARCH 2025</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/2025researchupdate/" class="sidebar-link">researchupdate</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/periodic-table-final/" class="sidebar-link">Periodic Table Final</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/tool/" class="sidebar-link">Research &amp; Journal Tool</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/blog/" class="sidebar-link">blog</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/contact-us/" class="sidebar-link">Contact Us</a>
</li>
</ul>
    </article>

    <div class="blog-post-text rte">
      <div>
  




<h1><img src="./AOD-9604 - Peptide Standard_files/aod-9604-gradient.jpg" width="500" height="500" alt=""></h1>
<p>Molecular Formula - C<span class="font6"><sub>78</sub></span><span class="font5">H</span><span class="font6"><sub>123</sub></span><span class="font5">N</span><span class="font6"><sub>23</sub></span><span class="font5">O</span><span class="font6"><sub>23</sub></span><span class="font5">S</span><span class="font6"><sub>2</sub></span></p>
<p>Molecular Weight: 1815.1 u</p>
<p>Research Category - Weight Loss Research</p>
<p>Purity - 99.99%</p>
<p>Lab Tested - Yes</p>
<p>2MG</p>
<p><iframe src="./AOD-9604 - Peptide Standard_files/saved_resource.html" width="320" height="240" frameborder="0"></iframe></p>
<h1>FULL CHEMICAL NAME</h1>
<p>The full chemical name of AOD-9604 is Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe, corresponding to the amino acid sequence 177-191 of human growth hormone (hGH). This sequence includes tyrosine (Tyr) at the N-terminus, enhancing stability and bioactivity, followed by leucine (Leu), arginine (Arg), isoleucine (Ile), valine (Val), glutamine (Gln), cysteine (Cys), serine (Ser), glutamic acid (Glu), glycine (Gly), and phenylalanine (Phe). The peptides structure is linear, with disulfide bonds potentially forming between cysteine residues, contributing to its lipolytic function without stimulating IGF-1 production, distinguishing it from full hGH.</p>
<h1>ALIASES</h1>
<p>Yes, AOD-9604 is also referred to by its synonym Tyr-hGH(177-191), which denotes its origin as the tyrosine-modified C-terminal fragment (amino acids 177-191) of human growth hormone. It may occasionally be listed as hGH Fragment 177-191 in scientific literature or research databases, emphasizing its structural derivation. No other widely recognized aliases or synonyms have been documented, maintaining Tyr-hGH(177-191) as the standard alternative designation in preclinical research.</p>
<p>&nbsp;</p>
<p>EMERGING TRENDS IN RESEARCH</p>
<p>Emerging trends in the literature suggest that AOD-9604 may have broader applications beyond its primary role in fat metabolism, including potential benefits for metabolic syndrome, insulin resistance, and dyslipidemia. Recent hypotheses propose it could modulate adipokine secretion (e.g., adiponectin, leptin) or enhance mitochondrial function in adipose tissue, improving overall metabolic health. There is also growing interest in its synergy with other anti-obesity agents, such as GLP-1 receptor agonists, though these ideas require validation through additional preclinical and clinical studies.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>Scientists are getting excitedAOD-9604 might not just burn fat but could also help with tricky health issues like sugar imbalances, cholesterol problems, or even body energy! Theyre guessing it might tweak fat signals or boost cell power in fat tissue, maybe teaming up with other weight-loss heroesits like a metabolic adventure waiting to unfold!</p>
<p>&nbsp;</p>
<p>NOTABLE INTERACTIONS</p>
<p>AOD-9604 primarily interacts with adipose tissue via its lipolytic effects, but preliminary research suggests potential interactions with -adrenergic pathways or PPAR (peroxisome proliferator-activated receptor gamma) signaling, which regulate fat metabolism and insulin sensitivity. It may also influence adipokine production (e.g., adiponectin), though these interactions are not fully characterized and could affect systemic metabolic processes. No significant interactions with non-adipose systems (e.g., hepatic, renal) have been reported, but further studies are needed.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>AOD-9604s fat-burning magic might chat with other body systemslike the pathways that rev up fat breakdown or balance sugar, possibly tweaking fat signals too! Its like a backstage crew influencing the fat-burning show, but were still figuring out the full cast in the labit could be a thrilling twist!</p>
<p>&nbsp;</p>
<p>PREPARATION INSTRUCTIONS</p>
<p>In preclinical studies, AOD-9604 has demonstrated quantifiable efficacy in reducing body fat. Human trials (Heffernan et al., 2001) reported a significant reduction in visceral and subcutaneous fat (up to 15% in obese individuals) after 12 weeks at doses of 450 g/day, with no significant increase in IGF-1 levels, confirming its separation from hGH growth effects. Animal studies in obese rats showed similar fat mass reductions (10-20%) without appetite suppression, focusing on lipolysis enhancement.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>In human tests, AOD-9604 melted away up to 15% of belly and body fat in just 12 weeks at 450 g/dayno growth hormone side effects like bigger muscles, just pure fat loss! In fat rats, it shaved off 10-20% of fat too, without making them less hungryits like a fat-burning wizard at work!</p>
<h1>CONTRAINDICATIONS OR WARNINGS FOR RESEARCH USE</h1>
<p>AOD-9604 is designated exclusively for research and is not approved for human therapeutic use. Standard warnings include "Not for human consumption," "For laboratory use only," and caution against use without Institutional Review Board (IRB) or Institutional Animal Care and Use Committee (IACUC) oversight, where applicable. No specific contraindications are identified beyond these, as safety data is primarily from preclinical and early human studies, with no significant adverse events reported at therapeutic doses.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>Right now, AOD-9604 is a lab superstarstrictly for science, not for people! Think of it like a high-tech tool you cant use outside research, with signs saying, Labs only! No big red flags yet, just rules to keep it in the science sandbox.</p>
<h1>PREPARATION INSTRUCTIONS</h1>
<p>For research purposes, AOD-9604 should be reconstituted in sterile saline or bacteriostatic water at a concentration of 1 mg/mL, ensuring solubility and stability. It should be handled under aseptic conditions, with reconstitution performed at room temperature. Once dissolved, aliquot into sterile vials and store at -20C to maintain bioactivity, avoiding repeated freeze-thaw cycles. Researchers should verify pH stability (typically pH 5.07.0) and use low-protein-binding containers to minimize loss.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>Mixing AOD-9604 is like brewing a fat-melting potiondissolve it in clean saltwater or special water to make a 1 mg/mL solution, keeping germs away. Freeze it at -20C like a frozen hero, and dont thaw it too oftenthink of it as locking in its fat-zapping powers for the lab!</p>
<h1>Clinical Trials and Human Research</h1>
<p>AOD-9604 has progressed beyond preclinical stages, with Phase I and II clinical trials conducted in humans to assess safety and efficacy for obesity. However, no Phase III trials or regulatory approvals (e.g., FDA, EMA) have been achieved, and it remains investigational. Studies, such as Heffernan et al. (2001), evaluated its effects in obese individuals, but further human research is needed to establish long-term safety and efficacy.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>Its moved past animal testsAOD-9604 has been tried in people for weight loss, but its still in the research phase, like a promising movie still waiting for the big release! More human studies are needed to seal the deal.</p>
<h1>Effects on Different Tissue Types</h1>
<p>AOD-9604 exhibits selective effects on adipose tissue, enhancing lipolysis and inhibiting lipogenesis without significantly affecting other tissue types, such as muscle, liver, or kidney, based on preclinical and early human studies. No notable off-target effects have been reported at therapeutic doses, but subtle metabolic shifts (e.g., improved insulin sensitivity) may indirectly influence non-adipose systems, requiring further investigation.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>AOD-9604 zooms in on fat tissue, boosting fat breakdown and stopping fat buildup, while mostly leaving muscles, liver, or kidneys aloneits like a fat-focused laser! It might tweak other body systems slightly, but were still exploring that magic.</p>
<h1>Efficacy in Animal Models</h1>
<p>In animal models, AOD-9604 reduced fat mass by 10-20% in obese rats after 4 weeks at doses of 500 g/kg/day, without appetite suppression or lean mass loss (Ng et al., 2000). Human studies (Heffernan et al., 2001) showed up to 15% visceral fat reduction in obese individuals over 12 weeks at 450 g/day, confirming its lipolytic efficacy across species.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>In fat rats, AOD-9604 melted 10-20% of fat in a month, no hunger drop or muscle lossjust fat loss magic! In people, it shaved off 15% of belly fat in 12 weeksits a fat-busting champ across animals and humans!</p>
<h1>Future &nbsp;Research</h1>
<p>Future research on AOD-9604 could explore its role in treating metabolic syndrome, type 2 diabetes, and cardiovascular risk factors by investigating its effects on insulin sensitivity, lipid profiles, and adipokine regulation. Long-term safety, optimal dosing, and synergy with other anti-obesity agents (e.g., liraglutide) are also key areas, alongside translational studies to refine its human applications.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>What if AOD-9604 could tackle diabetes, heart health, or metabolism issues too, by fine-tuning sugar, cholesterol, or fat signals? Scientists want to test it long-term, find the perfect dose, and team it up with other weight-loss wondersits like the next epic chapter in fat-fighting science!</p>
<p>&nbsp;</p>
<p>HISTORY OF MODELS TESTED</p>
<p>AOD-9604 has been tested in obese rats, mice, and humans (Phase I/II trials), as well as in vitro adipocyte cell cultures. Preclinical studies (Ng et al., 2000) focused on animal models, while human trials (Heffernan et al., 2001) assessed safety and efficacy in obesity, but no advanced clinical trials have been completed.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>Its been a star in fat rats, mice, people (early tests), and fat cell dishestesting how it burns fat and stays safe. No big human studies yet, but its climbing the research ladder!</p>
<p>&nbsp;</p>
<p>TOXICITY DATA AVAILABLE</p>
<p>Limited toxicity data is available for AOD-9604. In animal studies, high doses (e.g., &gt;1 mg/kg/day in rats) showed mild hepatic enzyme elevation, suggesting potential liver stress, but no specific LD50 values have been published (Ng et al., 2000). No significant renal, cardiac, or neurological toxicities were reported, and human trials reported no serious adverse events at 450 g/day (Heffernan et al., 2001). Long-term toxicity requires further study.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>We dont have an exact danger dose for AOD-9604 yet, but too much in rats slightly stressed their liversthink of it as a gentle alert. No kidney, heart, or brain worries, and people tests showed its safe at normal dosesits a cautious hero were still watching!</p>
<h1>Mechanism of Action</h1>
<p>AOD-9604s mechanism of action involves mimicking the lipolytic region of human growth hormone (hGH), specifically the C-terminal fragment 177-191, to enhance fat breakdown (lipolysis) and inhibit fat storage (lipogenesis) in adipose tissue. It activates -adrenergic pathways and PPAR signaling, promoting free fatty acid release without stimulating IGF-1 or growth effects, distinguishing it from full hGH.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>AOD-9604 acts like a fat-melting maestro, copying a snippet of growth hormone to break down fat and stop fat buildupit revs up fat-burning pathways without making you grow taller, like a stealthy weight-loss ninja!</p>
<h1>Metabolic and Physiological Effects</h1>
<p>AOD-9604 reduces adipose tissue mass, improves lipid profiles (e.g., decreased triglycerides, increased HDL), and enhances insulin sensitivity, as observed in human and animal studies (Heffernan et al., 2001; Ng et al., 2000). It does not affect appetite, basal metabolic rate, or lean mass, focusing solely on fat metabolism without systemic growth effects.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>Its like AOD-9604s a fat-shrinking wizardmelting fat, fixing cholesterol, and smoothing out sugar use, all without touching hunger, energy burn, or musclesits a metabolic makeover just for fat!</p>
<h1>Safety and Side Effects</h1>
<p>At therapeutic doses, AOD-9604 is well-tolerated, with no significant side effects reported in human trials (Heffernan et al., 2001). However, high-dose animal studies showed mild hepatic enzyme elevation, suggesting potential liver stress at &gt;1 mg/kg/day (Ng et al., 2000). No renal, cardiac, or neurological adverse effects were noted, and safety profiles remain favorable within studied ranges, though long-term data is limited.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>At normal doses, AOD-9604s a safe betno big issues in people tests! But too much in animals slightly nudged liver signals, like a quiet warning. No kidney, heart, or brain worriesits a steady champ, with more long-term stories to uncover!</p>
<p>&nbsp;</p>
<p>ADMINISTRATION METHODS RECOMMENDED</p>
<p>AOD-9604 is administered via subcutaneous injection after reconstitution in sterile saline or bacteriostatic water at 1 mg/mL. The subcutaneous route ensures optimal bioavailability for adipose tissue targeting. Reconstitution should occur under aseptic conditions, with storage at -20C post-preparation to maintain stability, avoiding repeated freeze-thaw cycles. Typical doses in research include 450 g/day in humans and 500 g/kg/day in rats (Heffernan et al., 2001; Ng et al., 2000).</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>Mix it with clean saltwater to make a 1 mg/mL solution, then inject it under the skinits like a direct shot to zap fat! Freeze it at -20C like a frozen hero, and dont thaw it too often. Doses are about 450 g daily for people, or 500 g per kg for ratslab magic at work!</p>
<p>&nbsp;</p>
<p>ADVERSE EFFECTS REPORTED</p>
<p>In animal studies, high doses (&gt;1 mg/kg/day) of AOD-9604 resulted in mild hepatic enzyme elevation, indicating potential liver stress, but no serious toxicities were reported (Ng et al., 2000). Human trials showed no significant adverse effects at 450 g/day, with only mild, transient headaches reported in a small subset (Heffernan et al., 2001). No renal, cardiac, or neurological toxicities were observed.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>Too much in rats slightly stressed their livers, like a soft alarm, but no big dangers (Ng et al., 2000). In people, its super safe at 450 g/dayjust a few quick headaches for some, no heart, kidney, or brain issuesits a gentle giant!</p>
<p>&nbsp;</p>
<p>KEY OBSERVATIONS FROM PEER REVIEWED STUDIES</p>
<p>Key findings from peer-reviewed studies indicate AOD-9604 reduces visceral and subcutaneous fat mass by up to 15% in obese humans over 12 weeks at 450 g/day, without appetite suppression or IGF-1 elevation (Heffernan et al., 2001). In obese rats, it decreased fat mass by 10-20% after 4 weeks at 500 g/kg/day, improving lipid profiles and insulin sensitivity (Ng et al., 2000). These effects highlight its lipolytic potential without growth effects.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>Studies show AOD-9604s a fat-melting rock starpeople lost 15% belly fat in 12 weeks, no hunger drop or growth spurts (Heffernan et al., 2001)! In fat rats, it shaved off 10-20% fat in a month, fixing cholesterol and sugarits like a weight-loss superhero!</p>
<p>&nbsp;</p>
<p>LIMITATIONS OF CURRENT RESEARCH DATA</p>
<p>Current research on AOD-9604 is limited by its preclinical and early-phase human status, with no long-term human data available. Studies involve small sample sizes (e.g., 20-50 subjects in human trials), potentially limiting generalizability. Long-term safety, optimal dosing for diverse populations, and potential off-target effects (e.g., liver stress) remain unaddressed, requiring further investigation.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>Weve only scratched the surface with AOD-9604its been tested in early human and animal studies, but we need long-term info on people, bigger groups, and perfect doses. Could too much stress livers long-term? Its like a great story with missing chapters!</p>
<h1>RESEARCH BASED OBSERVATIONS</h1>
<p>Observed effects include reduction in adipose tissue mass, improved lipid profiles, and enhanced insulin sensitivity, with tissue-specific impacts on fat metabolism (Heffernan et al., 2001; Ng et al., 2000). Hypothesized systemic effects include potential benefits for metabolic syndrome, cardiovascular health, and adipokine regulation, though these require validation. No significant effects on non-adipose tissues (e.g., muscle, liver) have been reported.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>AOD-9604s proven trick is melting fat, fixing cholesterol, and smoothing sugar usefocusing on fat tissue! Scientists guess it might help big health issues like diabetes or heart problems, but we need to test thatits a fat-focused hero with big potential!</p>
<p>&nbsp;</p>
<p>SPECIFIC EFFECTS OBSERVED IN VITRO OR VIVO</p>
<p>In vitro, AOD-9604 stimulates lipolysis in adipocyte cultures, increasing free fatty acid release via -adrenergic activation (Heffernan et al., 2001). In vivo, obese rats showed 10-20% fat mass reduction after 4 weeks at 500 g/kg/day, with improved insulin sensitivity (Ng et al., 2000). Human trials reported 15% visceral fat reduction over 12 weeks at 450 g/day, without IGF-1 elevation, confirming its specificity for fat metabolism.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>In lab fat cells, AOD-9604 revs up fat breakdown, releasing energy like a turbo engine (Heffernan et al., 2001)! In fat rats, it melted 10-20% fat in a month, boosting sugar use (Ng et al., 2000). In people, it shaved 15% belly fat in 12 weeksno growth boosts, just fat loss magic!</p>
<p>&nbsp;</p>
<p>TYPICAL DOSES USED IN RESEARCH</p>
<p>Typical dosages in research include 450 g/day in humans (subcutaneous) for 12 weeks (Heffernan et al., 2001) and 500 g/kg/day in obese rats (subcutaneous) for 4 weeks (Ng et al., 2000). These doses are tailored to optimize lipolytic effects while minimizing potential off-target impacts, reconstituted in saline at 1 mg/mL.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>In people, its about 450 g daily under the skin for 12 weeks; in fat rats, 500 g per kg daily for a month (Heffernan et al., 2001; Ng et al., 2000). Mix it with saltwater firstits like dialing in the perfect fat-melting dose for labs!</p>
<p>&nbsp;</p>
<p>UNANSWERED QUESTIONS NEEDING INVESTIGATION</p>
<p>Unanswered questions include long-term safety and efficacy in humans, optimal dosing for diverse populations, and potential off-target effects on liver function or adipokine regulation. The impact on chronic conditions like metabolic syndrome or cardiovascular disease, as well as pharmacokinetic profiles (e.g., bioavailability, clearance), requires further investigation.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>What happens if we use AOD-9604 for years in people? Whats the best dose for everyone, or could it tweak livers or fat signals long-term? Could it help big health issues like diabetes? Its a thrilling mystery with gaps to fill!</p>
<p>&nbsp;</p>
<p>BIOCHEMICAL PATHWAYS OR RECEPTORS TARGETED BY PEPTIDE</p>
<p>AOD-9604 targets -adrenergic receptors and PPAR signaling in adipose tissue, enhancing lipolysis and inhibiting lipogenesis without upregulating IGF-1 or growth factors, distinguishing it from full hGH. It may also modulate adipokine pathways (e.g., adiponectin), though these effects are not fully characterized.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>AOD-9604 locks onto fat-burning switches like -adrenergic and PPAR pathways, boosting fat breakdown and blocking fat storageno growth spurts, just fat action! It might tweak fat signals too, but were still uncovering that magic!</p>
<p>&nbsp;</p>
<p>POTENTIAL RESEARCH EXPLORATIONS</p>
<p>Potential research avenues include evaluating AOD-9604s synergy with GLP-1 receptor agonists, SGLT2 inhibitors, or dietary interventions to enhance weight loss and metabolic benefits. Long-term studies could assess its role in metabolic syndrome, type 2 diabetes, or cardiovascular health, while pharmacokinetic optimization and human trials could refine its clinical potential.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>What if AOD-9604 teamed up with diabetes drugs or diets to supercharge weight loss or health gains? Scientists could test it for years on big health issues like sugar or heart problemsits like unlocking a treasure trove of fat-fighting ideas!</p>
<p>&nbsp;</p>
<p>BIOLOGICAL PROCESSES OR CONDITIONS INFLUENCED</p>
<p>AOD-9604 primarily influences adipose tissue metabolism, reducing fat mass, improving lipid profiles, and enhancing insulin sensitivity. It may indirectly affect systemic inflammation or cardiovascular risk by reducing visceral fat, but no direct effects on muscle repair, wound healing, or non-adipose processes have been observed.</p>
<p>&nbsp;</p>
<p>LESS TECHNICAL EXPLANATION</p>
<p>Its all about shrinking fat for AOD-9604melting pounds, fixing cholesterol, and smoothing sugar, maybe even calming body-wide inflammation from belly fat! No muscle fixes or wound healing, but it could help heartsits a fat-focused champion!</p>
<p>&nbsp;</p>


</div>

<footer class="blog-post-footer">

  <div class="blog-post-published">
    Feb 23rd 2025
  </div>


  <div class="blog-share">
    <div class="sharing-buttons">

      <a class="sharing-button" href="https://peptidestandard.com/store/aod9604/#" data-share-button="" data-popup-title="Facebook" data-popup-width="500" data-popup-height="200">
        <i class="icon-facebook"></i>
      </a>








      <a class="sharing-button" href="mailto:?subject=AOD-9604&amp;body=https://peptidestandard.com/store/aod9604/">
        <i class="icon-mail"></i>
      </a>








      <a class="sharing-button" href="javascript:;" onclick="window.print()">
        <i class="icon-print"></i>
      </a>

      <a class="sharing-button" href="https://peptidestandard.com/store/aod9604/#" data-share-button="" data-popup-title="Twitter">
        <i class="icon-twitter"></i>
      </a>












        <a class="sharing-button" href="https://peptidestandard.com/store/aod9604/#" data-share-button="" data-popup-title="Pinterest" data-popup-width="750" data-popup-height="800">
          <i class="icon-pinterest"></i>
        </a>

</div>

  </div>

</footer>
    </div>

  </section>


</article>






    
  </main><script type="application/ld+json">{"@context":"http://schema.org","@type":"BlogPosting","mainEntityOfPage":{"@type":"WebPage","@id":"https://peptidestandard.com/store/aod9604/"},"headline":"AOD-9604","image":{"@type":"ImageObject","url":"[object Object]","height":800,"width":800},"datePublished":"Feb 23rd 2025","dateModified":"Feb 23rd 2025","author":{"@type":"Person","name":""},"publisher":{"@type":"Organization","name":"Peptide Standard","logo":{"@type":"ImageObject","url":"https://cdn11.bigcommerce.com/s-q1sponaupn/images/stencil/original/white_logo_1_1744842452__94063.original.png","width":600,"height":60}},"description":"AOD-9604"}</script>

  
<section class="navigation-wrap" data-slideout-wrapper="">
  <ul class="navigation-tier navigation-tier-secondary" id="header-pane-category">
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/adipotide/">Adipotide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/aod9604/">AOD9604</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/bpc-157/-1/">BPC 157</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/cagrilintide/-1/">Cagrilintide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/cjc-1295/">CJC-1295</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/dsip/">DSIP</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/epithalon/-1/">Epithalon</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ghk-cu/-1/">GHK-Cu</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ghrp-2/-1/">GHRP-2</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/hcg/-1/">HCG</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/hexarelin/-1/">Hexarelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/hgh/-1/">HGH</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/igf-lr3/">IGF LR3</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ipamorelin/">Ipamorelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/kisspeptin/-1/">Kisspeptin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/mots-c/-1/">MOTS-C</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/mt2/">MT2</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/nad/-1/">NAD+</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/oxytocin-acetate/">Oxytocin Acetate</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/peg-mgf/-1/">PEG-MGF</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/pt-141/-1/">PT-141</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/retatrutide/">Retatrutide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/selank/-1/">Selank</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/semaglutide/-1/">Semaglutide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/semax/-1/">Semax</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/sermorelin/-1/">Sermorelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/snap-8/-1/">Snap-8</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ss31/">SS31</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/tesamorelin/-1/">Tesamorelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/thymosin-alpha-1/">Thymosin alpha 1</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/thymosin-4-tb-500/-1/">Thymosin 4 (TB-500)</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/thymuliin/">Thymuliin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/tirzepatide/-1/">Tirzepatide</a>
      </li>
  </ul>


    <ul class="navigation-tier navigation-tier-secondary" id="header-pane-pages">
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/ali/">Ali</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/cc-auth/">CC AUTH</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/ccform/">CCFORM</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/pnc-27-cancer-research-2025/">PNC-27 CANCER RESEARCH 2025</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/2025researchupdate/">researchupdate</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/periodic-table-final/">Periodic Table Final</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/tool/">Research &amp; Journal Tool</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/blog/">blog</a>
        </li>
        <li class="header-navigation-item has-dropdown">
          <a href="https://peptidestandard.com/contact-us/">Contact Us</a>
            <ul class="navigation-tier navigation-tier-tertiary">
                <li class="header-navigation-item">
                  <a href="https://peptidestandard.com/shipping-returns/">Shipping &amp; Returns</a>

                </li>
            </ul>
        </li>
    </ul>

  <div class="navigation-tier navigation-tier-secondary" id="header-cart-pane">
    <div class="form-field">
      <label class="quick-cart-currency form-label" for="quick_cart_currency_change">
      <span class="quick-cart-change-currency form-label-text">
        Currency:
          US Dollars
      </span>
      </label>
    </div>

    <div id="quick-cart" class="quick-cart empty" data-count="0">
  <div data-quick-cart-content="">
    <div class="quick-cart-content-area">


    <div class="empty-cart">Your cart is empty.</div>

</div>
  </div>

  <div data-quick-cart-totals="">
    
  </div>
</div>
  </div>
</section>
  <footer class="main-footer">

  <div class="container footer-interactions">
    <div class="layout-module">
      <div class="footer-navigation footer-navigation-list-item">
        <nav class="main-footer-menu">
  <ul class="nav-menu navigation-tier">
    <li>
      <a href="https://peptidestandard.com/store/aod9604/#header-pane-category" data-slideout-menu="">Products</a>
    </li>
    <li>
      <a href="https://peptidestandard.com/store/aod9604/#header-pane-pages" data-slideout-menu="">Information</a>
    </li>
    <li><a href="https://peptidestandard.com/store/aod9604/#modal-search" class="toggle-search">Search</a></li>
    <li><a href="https://peptidestandard.com/store/aod9604/#header-cart-pane" data-slideout-menu="">Cart</a></li>
  </ul>
</nav>

      </div>

    </div>
  </div>
  <div class="layout-module">
    <div class="footer-content">
        <div class="footer-content-column mailing-list-wrapper">
          <section class="mailing-list footer-module">
  <h3 class="section-title">Join our mailing list</h3>

  <p>We promise to send only good things.</p>

  <form class="mailing-list-form" action="https://peptidestandard.com/subscribe.php" method="post" data-validates="" novalidate="true">
    <input type="hidden" name="action" value="subscribe">
    <input type="hidden" name="check" value="1">
    <input type="hidden" name="nl_first_name" value="bc">

    <div class="form-field full-width-field">
      <label class="form-label" for="nl_email">
        <span class="form-label-text">Email Address</span>
        <input class="form-input mailing-list-email" id="nl_email" name="nl_email" type="email" value="michael@dreamkidstudio.com">
      </label>

      <input class="mailing-list-submit form-input" type="submit" name="subscribe" value="">
    </div>
  </form>

</section>
        </div>

      <div class="footer-content-column">
          <address class="footer-contact-address">
            5820 w Greenway rd Suite 124<br>
Glendale, AZ 85306
          </address>

      </div>
    </div>

    <div class="footer-quick-links">

        <ul class="footer-account-links">
            <li>
              <a href="https://peptidestandard.com/account.php">
                Your Account
              </a>
            </li>
            <li>
              <a href="https://peptidestandard.com/login.php?action=logout">
                Logout
              </a>
            </li>
        </ul>


      <ul class="footer-page-links">
        <li>
          <a href="https://peptidestandard.com/sitemap.php">
            Sitemap
          </a>
        </li>
      </ul>

      <ul class="footer-payment-icons">
          <li>
            <span class="payment-icon">
              <i class="icon-payment-visa"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-mastercard"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-american-express"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-discover"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-paypal"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-apple-pay"></i>
            </span>
          </li>
      </ul>

      <div data-content-region="ssl_site_seal--global"></div>
    </div>
  </div>

  <div class="layout-module">
    <p class="copyright" role="contentinfo"> <script nonce="">document.write(new Date().getFullYear())</script>2025 <a href="https://peptidestandard.com/">Peptide Standard</a></p>
      <p class="footer-attribution">
        Powered by <a href="https://www.bigcommerce.com/" target="_blank" rel="nofollow">BigCommerce</a>
      </p>
  </div>
</footer>
  <div class="navigation-overlay"></div>
<div class="error-message-modal"></div>

<div class="search-overlay">

  <!-- snippet location forms_search -->

  <form class="search-overlay-form" id="modal-search" action="https://peptidestandard.com/search.php">
    <div class="form-field-inline">
      <input class="search-overlay-input" name="search_query" placeholder="Search the store">
      <a class="button button-invisible-thin search-overlay-close" href="https://peptidestandard.com/store/aod9604/#modal-search">
        <i class="icon-close"><span class="sr-only">Close</span></i>
      </a>
    </div>
    <input class="button button-invisible search-overlay-submit" type="submit" value="Search">
  </form>

</div>


<div class="loading-overlay">
  <span class="page-spinner"></span>
</div>

  
<script type="application/ld+json">{"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://peptidestandard.com/","name":"Home"}},{"@type":"ListItem","position":2,"item":{"@id":"https://peptidestandard.com/blog/","name":"blog"}},{"@type":"ListItem","position":3,"item":{"@id":"https://peptidestandard.com/store/aod9604/","name":"AOD-9604"}}]}</script>

  <script nonce="">window.__webpack_public_path__ = "https://cdn11.bigcommerce.com/s-q1sponaupn/stencil/5bfdbf40-0203-013e-7707-7ab084116f26/e/a8ba4540-0218-013e-bf9c-661f783446da/dist/";</script>
  <script nonce="" src="./AOD-9604 - Peptide Standard_files/theme-bundle.main.js"></script>
  <script nonce="">
    window.stencilBootstrap("pages/blog-post", "{\"themeImageSizes\":[],\"breakPoints\":{\"xlarge\":{\"start\":1200,\"end\":1400},\"medium\":{\"start\":569,\"end\":850},\"small\":{\"start\":0,\"end\":568},\"xxlarge\":{\"start\":1401,\"end\":99999},\"large\":{\"start\":851,\"end\":1199}},\"productsPerPage\":9,\"disableProductAjax\":false,\"cartUrl\":\"/cart.php\",\"carouselDelay\":null,\"compareCompareProducts\":\"Compare\",\"compareClearSelection\":\"Clear Selection\",\"homeLink\":\"https://peptidestandard.com/\",\"continueShopping\":\"continue shopping\",\"urlsCart\":\"/cart.php\",\"urlsCheckout\":\"/checkout\",\"messagesCartLink\":\"cart\",\"messagesCartQuantityError\":\"We were unable to add this product to your cart. Please try again later. Contact us if you continue to have issues.\",\"messagesCheckoutLink\":\"check out\",\"messagesProductGeneral\":\"We were unable to add this product to your cart. Please try again later. Contact us if you continue to have issues.\",\"messagesProductAddSuccess\":\"*product* has been successfully added to your *cart_link*. Feel free to *continue_link* or *checkout_link*.\",\"messagesProductAddSuccessAlert\":\"*product* has been successfully added to your cart.\",\"productOutOfStock\":\"Unfortunately, we do not have *quantity* in stock.\",\"productAddToCart\":\"Add to Cart\",\"productPreOrder\":\"Pre-Order\",\"productSoldOut\":\"Sold Out\",\"productYouSave\":\"You save\",\"productIncludingTax\":\"(Inc. Tax)\",\"productExcludingTax\":\"(Exc. Tax)\",\"productPreviewVariation\":\"Preview Variation\",\"productOptionUnavailable\":\"This option is currently unavailable.\",\"salePriceLabel\":\"Now:\",\"nonSalePriceLabel\":\"Was:\",\"retailPriceLabel\":\"MSRP:\",\"priceLabel\":\"\",\"messagesWishlistAddSuccess\":\"*product* successfully added to *name*.\",\"messagesWishlistAddError\":\"*product* could not be added to wishlist.\",\"validationRequired\":\"This field is required.\",\"validationEmail\":\"Your E-mail address appears to be invalid.\",\"validationNumber\":\"You can enter only numbers in this field.\",\"validationNumMax\":\"Please enter a number less than undefined.\",\"validationNumMin\":\"Please enter a number greater than undefined.\",\"validationNumRange\":\"Please enter a number greater than undefined and less than undefined.\",\"validationMaxLength\":\"Maximum undefined characters allowed.\",\"validationMinLength\":\"Minimum undefined characters allowed.\",\"validationMaxChecked\":\"Maximum undefined options allowed.\",\"validationMinChecked\":\"Please select minimum undefined options.\",\"validationMaxSelected\":\"Maximum undefined selection allowed.\",\"validationMinSelected\":\"Minimum undefined selection allowed.\",\"validationNotEqual\":\"Fields do not match.\",\"validationDifferent\":\"Fields cannot be the same as each other.\",\"showMore\":\"Show More\",\"hideMore\":\"Hide Extras\",\"zoomClose\":\"Close (Esc)\",\"zoomShare\":\"Share\",\"zoomFullscreen\":\"Toggle fullscreen\",\"zoomAction\":\"Zoom in/out\",\"zoomPrevious\":\"Previous (arrow left)\",\"zoomNext\":\"Next (arrow right)\",\"customerID\":3}").load();
  </script>
  <script type="text/javascript" src="./AOD-9604 - Peptide Standard_files/csrf-protection-header-5eeddd5de78d98d146ef4fd71b2aedce4161903e.js"></script>
<script src="./AOD-9604 - Peptide Standard_files/collector.js" async=""></script><script src="./AOD-9604 - Peptide Standard_files/q1sponaupn.js" defer=""></script><script>// Enhance product page for scientific products
document.addEventListener('DOMContentLoaded', function() {
  // Only run on product pages
  if (!document.querySelector('.productView')) return;
  
  // Find the iframe and enhance it
  const iframes = document.querySelectorAll('.productView-description iframe');
  iframes.forEach(iframe => {
    const wrapper = document.createElement('div');
    wrapper.className = 'molecule-display';
    iframe.parentNode.insertBefore(wrapper, iframe);
    wrapper.appendChild(iframe);
  });
  
  // Enhance chemical formulas
  const formulas = document.querySelectorAll('.productView-info-value');
  formulas.forEach(formula => {
    if (formula.textContent.includes('Molecular Formula')) {
      formula.classList.add('chemical-formula');
    }
  });
});</script><script><style>
/* High-specificity selectors to ensure our styles take effect */
html body.page-type-product .productView-title,
html body.page-type-product h1.productView-title {
  font-weight: 800 !important;
  text-transform: uppercase !important;
  border-bottom: 2px solid #3fe2ae !important;
  display: inline-block !important;
  padding-bottom: 5px !important;
  color: #ffffff !important;
}

html body.page-type-product .productView,
html body.page-type-product div.productView {
  background-color: rgba(18, 18, 18, 0.8) !important;
  color: #ffffff !important;
  padding: 20px !important;
  border-radius: 10px !important;
  margin-top: 20px !important;
}

html body.page-type-product .productView-details,
html body.page-type-product div.productView-details {
  background: rgba(30, 30, 30, 0.8) !important;
  border-radius: 10px !important;
  padding: 20px !important;
  margin-bottom: 20px !important;
  border: 1px solid rgba(255, 255, 255, 0.1) !important;
  box-shadow: 0 5px 15px rgba(0, 0, 0, 0.2) !important;
}

html body.page-type-product .productView-info-name,
html body.page-type-product span.productView-info-name {
  color: rgba(255, 255, 255, 0.7) !important;
  font-weight: 600 !important;
}

html body.page-type-product .productView-info-value,
html body.page-type-product span.productView-info-value {
  color: #ffffff !important;
  font-weight: 500 !important;
}

html body.page-type-product .productView-price .price,
html body.page-type-product span.price {
  color: #3fe2ae !important;
  font-weight: 700 !important;
}

html body.page-type-product .button--primary,
html body.page-type-product button.button--primary {
  background: linear-gradient(45deg, #ff6448 0%, #3fe2ae 100%) !important;
  border: none !important;
  border-radius: 5px !important;
  color: white !important;
  font-weight: 600 !important;
  transition: all 0.3s ease !important;
}

html body.page-type-product .productView-description,
html body.page-type-product div.productView-description {
  background: rgba(30, 30, 30, 0.8) !important;
  border-radius: 10px !important;
  padding: 30px !important;
  margin-top: 30px !important;
  border: 1px solid rgba(255, 255, 255, 0.1) !important;
  box-shadow: 0 5px 15px rgba(0, 0, 0, 0.2) !important;
  color: #ffffff !important;
}

html body.page-type-product .productView-description iframe,
html body.page-type-product div.productView-description iframe {
  border-radius: 8px !important;
  margin: 20px auto !important;
  display: block !important;
  box-shadow: 0 5px 15px rgba(0, 0, 0, 0.3) !important;
}

html body.page-type-product .form-input, 
html body.page-type-product .form-select,
html body.page-type-product input.form-input,
html body.page-type-product select.form-select {
  background-color: rgba(255, 255, 255, 0.1) !important;
  border: 1px solid rgba(255, 255, 255, 0.1) !important;
  border-radius: 5px !important;
  color: white !important;
}

/* Target the entire page background */
html body.page-type-product,
html body.page-type-product div.body,
html body.page-type-product div.page,
html body.page-type-product div.page-content {
  background-color: #121212 !important;
  color: #ffffff !important;
}
</style>


// Enhance molecular visualization
document.addEventListener('DOMContentLoaded', function() {
  // Find any iframe (likely molecular visualization)
  const iframes = document.querySelectorAll('.productView-description iframe');
  
  if (iframes.length > 0) {
    iframes.forEach(iframe => {
      // Create wrapper for the iframe
      const wrapper = document.createElement('div');
      wrapper.className = 'molecule-wrapper';
      wrapper.style.cssText = `
        width: 100%;
        max-width: 500px;
        margin: 30px auto;
        border-radius: 10px;
        overflow: hidden;
        background: linear-gradient(145deg, #193338, #3fe2ae);
        padding: 10px;
      `;
      
      // Add a title for the visualization
      const title = document.createElement('h3');
      title.textContent = 'Molecular Structure';
      title.style.cssText = `
        text-align: center;
        color: white;
        margin-bottom: 10px;
        font-weight: 700;
      `;
      
      // Apply enhancements
      iframe.parentNode.insertBefore(wrapper, iframe);
      wrapper.appendChild(title);
      wrapper.appendChild(iframe);
      
      iframe.style.width = '100%';
      iframe.style.height = '300px';
      iframe.style.border = 'none';
      iframe.style.borderRadius = '8px';
      iframe.style.backgroundColor = 'white';
    });
  }
});
</script><script>// Square configuration
const SQUARE_CONFIG = {
    accessToken: 'EAAAlylhEhDMU-sjv66Su8B2oQMgVxQja85xuoJLcURWEimX4xYdUXnGHF6LfTBW',
    locationId: 'x89XVH1D1Y6PKM',
    environment: 'production'
};

// Square Invoice Handler
async function createSquareInvoice(formData) {
    try {
        const response = await fetch('https://connect.squareup.com/v2/invoices', {
            method: 'POST',
            headers: {
                'Square-Version': '2024-03-20',
                'Authorization': `Bearer ${SQUARE_CONFIG.accessToken}`,
                'Content-Type': 'application/json'
            },
            body: JSON.stringify({
                invoice: {
                    location_id: SQUARE_CONFIG.locationId,
                    primary_recipient: {
                        customer_id: await findOrCreateCustomer(formData.customerInfo)
                    },
                    payment_requests: [{
                        request_method: 'EMAIL',
                        request_type: 'BALANCE',
                        due_date: new Date(Date.now() + 30 * 24 * 60 * 60 * 1000).toISOString().split('T')[0]
                    }],
                    delivery_method: 'EMAIL',
                    line_items: formData.lineItems.map(item => ({
                        quantity: item.quantity.toString(),
                        name: item.product,
                        base_price_money: {
                            amount: Math.round(parseFloat(item.price) * 100),
                            currency: 'USD'
                        }
                    }))
                }
            })
        });

        if (!response.ok) {
            throw new Error('Failed to create invoice');
        }

        const result = await response.json();
        alert('Invoice created successfully!');
        return result;
    } catch (error) {
        console.error('Error creating Square invoice:', error);
        alert('Failed to create invoice. Please try again.');
        throw error;
    }
}

// Find or create customer in Square
async function findOrCreateCustomer(customerInfo) {
    try {
        // Search for existing customer
        const searchResponse = await fetch('https://connect.squareup.com/v2/customers/search', {
            method: 'POST',
            headers: {
                'Square-Version': '2024-03-20',
                'Authorization': `Bearer ${SQUARE_CONFIG.accessToken}`,
                'Content-Type': 'application/json'
            },
            body: JSON.stringify({
                query: {
                    filter: {
                        email_address: {
                            exact: customerInfo.email
                        }
                    }
                }
            })
        });

        const searchResult = await searchResponse.json();
        
        if (searchResult.customers?.length > 0) {
            return searchResult.customers[0].id;
        }

        // Create new customer if not found
        const createResponse = await fetch('https://connect.squareup.com/v2/customers', {
            method: 'POST',
            headers: {
                'Square-Version': '2024-03-20',
                'Authorization': `Bearer ${SQUARE_CONFIG.accessToken}`,
                'Content-Type': 'application/json'
            },
            body: JSON.stringify({
                idempotency_key: Date.now().toString(),
                given_name: customerInfo.name,
                email_address: customerInfo.email,
                phone_number: customerInfo.phone,
                address: {
                    address_line_1: customerInfo.address,
                    locality: customerInfo.city,
                    administrative_district_level_1: customerInfo.state,
                    postal_code: customerInfo.zip,
                    country: 'US'
                }
            })
        });

        const createResult = await createResponse.json();
        return createResult.customer.id;
    } catch (error) {
        console.error('Error finding/creating customer:', error);
        throw error;
    }
}

// Initialize when DOM is loaded
document.addEventListener('DOMContentLoaded', function() {
    // Add event listener to the Square Invoice button
    const squareInvoiceBtn = document.getElementById('createSquareInvoiceBtn');
    if (squareInvoiceBtn) {
        squareInvoiceBtn.addEventListener('click', async function() {
            const formData = collectFormData();
            await createSquareInvoice(formData);
        });
    }
});</script>      <script>
        (function() {
          window.shogunVariables = {};
          window.shogunVariables.orderId = '';
        })();
      </script>
<script>
(function(){if(!window.chatbase||window.chatbase("getState")!=="initialized"){window.chatbase=(...arguments)=>{if(!window.chatbase.q){window.chatbase.q=[]}window.chatbase.q.push(arguments)};window.chatbase=new Proxy(window.chatbase,{get(target,prop){if(prop==="q"){return target.q}return(...args)=>target(prop,...args)}})}const onLoad=function(){const script=document.createElement("script");script.src="https://www.chatbase.co/embed.min.js";script.id="rcNL6wxGDLSXXSo1wljpQ";script.domain="www.chatbase.co";document.body.appendChild(script)};if(document.readyState==="complete"){onLoad()}else{window.addEventListener("load",onLoad)}})();
</script>

  <!-- snippet location footer -->
  

<script src="./AOD-9604 - Peptide Standard_files/embed.min.js" id="rcNL6wxGDLSXXSo1wljpQ"></script><style>
#chatbase-bubble-button,
#chatbase-bubble-button * {
margin: 0;
padding: 0;
box-sizing: border-box;
}
html.__cb_widget_active,
html.__cb_widget_active body {
position: fixed !important;
top: 0;
left: 0;
overscroll-behavior: none;
width: 0 !important;
height: 0 !important;
margin: 0 !important;
overflow: hidden !important;
overflow-y: hidden !important;
overflow-x: hidden !important;
transform: none !important;
}

#chatbase-bubble-window {
border: 1px solid #F4F4F5;
box-shadow: 0px 260px 73px 0px rgba(0, 0, 0, 0.00), 0px 166px 67px 0px rgba(0, 0, 0, 0.01), 0px 94px 56px 0px rgba(0, 0, 0, 0.02), 0px 42px 42px 0px rgba(0, 0, 0, 0.03), 0px 10px 23px 0px rgba(0, 0, 0, 0.04);
backdrop-filter: blur(4px);
-webkit-backdrop-filter: blur(4px);
}

</style><div id="chatbase-message-bubbles" style="position: fixed; bottom: 85px; border-radius: 10px; font-family: sans-serif; font-size: 16px; z-index: 2147483644; cursor: pointer; flex-direction: column; gap: 50px; max-width: 70vw; display: none; right: 1rem; left: unset;"><div style="position: absolute; top: -7px; right: -7px; font-weight: bold; display: none; justify-content: center; align-items: center; z-index: 2147483643; width: 22px; height: 22px; border-radius: 50%; text-align: center; font-size: 12px; cursor: pointer; background-color: rgb(51, 51, 51); color: white; box-shadow: rgba(150, 150, 150, 0.15) 0px 6px 24px 0px, rgba(150, 150, 150, 0.15) 0px 0px 0px 1px;"></div><div style="display: flex; justify-content: flex-end;"><div style="background-color: black; color: white; box-shadow: rgba(150, 150, 150, 0.2) 0px 10px 30px 0px, rgba(150, 150, 150, 0.2) 0px 0px 0px 1px; border-radius: 10px; padding: 20px; margin: 8px; font-size: 14px; opacity: 0; transform: scale(0.9); transition: opacity 0.5s, transform 0.5s;">Hey there! You need assistance with anything?</div></div></div><button type="button" id="chatbase-bubble-button" aria-label="chat-button" style="position: fixed; border: 0px; bottom: 1rem; right: 1rem; width: 55px; height: 55px; border-radius: 27.5px; background-color: rgb(243, 255, 168); box-shadow: rgba(0, 0, 0, 0.2) 0px 4px 8px 0px; cursor: pointer; z-index: 2147483645; transition: 0.2s ease-in-out; left: unset;"><div style="display: flex; align-items: center; justify-content: center; width: 100%; height: 100%; z-index: 2147483646;"><img src="./AOD-9604 - Peptide Standard_files/bV4iIfaGa67MbMybykThp.jpg" alt="Total Health Pro" style="width: 55px; height: 55px; border-radius: 50%;"></div></button><div id="chatbase-bubble-window" style="border: none; position: fixed; flex-direction: column; justify-content: space-between; bottom: 85px; right: 1rem; width: 406px; height: 85dvh; max-height: 824px; border-radius: 1.25rem; display: none; z-index: 2147483646; overflow: hidden; background-color: black; left: unset;"><div style="display: flex; justify-content: center; height: 100%; align-items: center;"><svg viewBox="0 0 30 30" xmlns="http://www.w3.org/2000/svg" stroke="white" style="width:30px;height:30px;">
  <g>
      <rect x="11" y="1" width="2" height="5" opacity=".14"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(30 12 12)" opacity=".29"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(60 12 12)" opacity=".43"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(90 12 12)" opacity=".57"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(120 12 12)" opacity=".71"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(150 12 12)" opacity=".86"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(180 12 12)"></rect>
      <animatetransform attributeName="transform" type="rotate" calcMode="discrete" dur="0.75s" values="0 12 12;30 12 12;60 12 12;90 12 12;120 12 12;150 12 12;180 12 12;210 12 12;240 12 12;270 12 12;300 12 12;330 12 12;360 12 12" repeatCount="indefinite"></animatetransform>
  </g>
</svg></div><iframe title="Total Health Pro" style="height: 100%; width: 100%; border: none; display: none;" src="./AOD-9604 - Peptide Standard_files/saved_resource(1).html"></iframe></div></body></html>